TABLE 2
COMMUNITY PRESCRIPTION DRUG USE, 
IN DDDS/1000/DAY, FOR 2001 TO 2003
Table 2 lists most drugs on the Australian market by defined daily dose (DDD) per 1000 of the population per day from 2001 to 2003. To be listed in Table 2 the drugs need to have both an assigned DDD and an entry in Table 1 (i.e. more than 110 prescriptions dispensed in 2003). Items are arranged on the ATC code by generic name and the DDD/1000/day is given for both the subsidised ‘PBS/RPBS’ and the non-subsidised ‘survey’ components. Consult the index (Page 255) by generic drug name to obtain the appropriate ATC code.
Please note that items which have a level of usage low enough to result in an entry of 0.000 DDDs/1000 population/day (i.e. not registering at 3 decimal points) over each of the three years in the series are not included in Table 2.
An index by the 2nd level of the ATC classification follows:
Alimentary tract and metabolism	Page No
A01 	STOMATOLOGICAL PREPARATIONS 	175
A02 	DRUGS FOR ACID RELATED DISORDERS 	176
A03 	DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS 	177
A04 	ANTIEMETICS AND ANTINAUSEANTS 	178
A05 	BILE AND LIVER THERAPY 	179
A06 	LAXATIVES 	180
A07 	ANTIDIARRHOEALS, INTESTINAL 
	ANTIINFLAMMATORY/ANTIINFECTIVES 	181
A08 	ANTIOBESITY PREPARATIONS, EXCLUDING DIET PRODUCTS 	182
A10 	ANTIDIABETIC THERAPY 	183
A11 	VITAMINS 	185
A12 	MINERAL SUPPLEMENTS 	186
A14 	ANABOLIC AGENTS FOR SYSTEMIC USE	187

Blood and blood forming organs
B01 	ANTITHROMBOTIC AGENTS 	188
B02 	ANTIHAEMORRHAGICS 	189
B03 	ANTIANAEMIC PREPARATIONS	190
Cardiovascular system
C01 	CARDIAC THERAPY 	191
C02 	ANTIHYPERTENSIVES 	193
C03 	DIURETICS 	194
C04 	PERIPHERAL VASODILATORS 	196
C07 	BETA BLOCKING AGENTS 	197
C08 	CALCIUM CHANNEL BLOCKERS 	198
C09 	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM 	199
C10 	SERUM LIPID REDUCING AGENTS	201
Dermatologicals
D01 	ANTIFUNGALS FOR DERMATOLOGICAL USE 	202
D05 	ANTIPSORIATICS 	203
D10 	ANTI-ACNE PREPARATIONS 	204
Genitourinary system and sex hormones
G01 	GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS 	205
G02 	OTHER GYNAECOLOGICALS 	206
G03 	SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM 	207
G04 	UROLOGICALS 	210
Systemic hormonal preparations, excluding sex hormones
H01 	PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES 	211
H02 	CORTICOSTEROIDS FOR SYSTEMIC USE 	212
H03 	THYROID THERAPY 	213
H04 	PANCREATIC HORMONES 	214
H05 	CALCIUM HOMEOSTASIS 	215
General antiinfectives for systemic use
J01 	ANTIBACTERIALS FOR SYSTEMIC USE 	216
J02 	ANTIMYCOTICS FOR SYSTEMIC USE 	220
J04 	ANTIMYCOBACTERIALS 	221
J05 	ANTIVIRALS FOR SYSTEMIC USE 	222

Antineoplastic and immuno-modulating agents
L02 	ENDOCRINE THERAPY 	223
L03 	IMMUNOSTIMULANTS 	225
L04 	IMMUNO-SUPPRESSIVE AGENTS 	226
Musculo-skeletal system
M01 	ANTI-INFLAMMATORY AND ANTI-RHEUMATIC PRODUCTS 	227
M03 	MUSCLE RELAXANTS 	229
M04 	ANTI-GOUT PREPARATIONS 	230
M05 	DRUGS FOR TREATMENT OF BONE DISEASES 	231
Nervous system
N02 	ANALGESICS 	232
N03 	ANTI-EPILEPTICS 	234
N04 	ANTI-PARKINSON DRUGS 	236
N05 	PSYCHOLEPTICS 	237
N06 	PSYCHOANALEPTICS 	240
N07 	OTHER NERVOUS SYSTEM DRUGS 	243
Anti-parasitic products, insecticides and repellents
P01 	ANTI-PROTOZOALS 	244
P02 	ANTHELMINTICS	245
Respiratory system
R01 	NASAL PREPARATIONS 	246
R03 	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES 	247
R05 	COUGH AND COLD PREPARATIONS 	249
R06 	ANTI-HISTAMINES FOR SYSTEMIC USE 	250
Sensory organs
S01 	OPHTHALMOLOGICALS 	251
Various
V03 	ALL OTHER THERAPEUTIC PRODUCTS	253

atc	source	2001	2002	2003

ALIMENTARY TRACT AND METABOLISM
STOMATOLOGICAL PREPARATIONS
STOMATOLOGICAL PREPARATIONS
ANTIINFECTIVES FOR LOCAL ORAL TREATMENT
AMPHOTERICIN
A01AB04	PBS/RPBS	 0.102	 0.100	 0.094
	SURVEY	 0.026	 0.023	 0.020
CHLORHEXIDINE
A01AB03	PBS/RPBS	 0.004	 0.005	 0.004
	SURVEY	 0.003	 0.005	 0.005
MICONAZOLE
A01AB09	SURVEY	 0.008	 0.008	 0.007
NYSTATIN
A01AB11	PBS/RPBS	 0.028	 0.028	 0.027
	SURVEY	 0.009	 0.009	 0.008
ALIMENTARY TRACT AND METABOLISM
DRUGS FOR ACID RELATED DISORDERS
DRUGS FOR PEPTIC ULCER AND GORD
H2-RECEPTOR ANTAGONISTS
CIMETIDINE
A02BA01	PBS/RPBS	 0.612	 0.433	 0.321
	SURVEY	 0.007	 0.003	 0.005
FAMOTIDINE
A02BA03	PBS/RPBS	 3.143	 1.876	 1.268
	SURVEY	 0.625	 0.333	 0.231
NIZATIDINE
A02BA04	PBS/RPBS	 1.293	 0.691	 0.464
	SURVEY	 0.351	 0.140	 0.086
RANITIDINE HYDROCHLORIDE
A02BA02	PBS/RPBS	14.622	10.419	 8.056
	SURVEY	 2.136	 1.635	 1.157
PROSTAGLANDINS
MISOPROSTOL
A02BB01	PBS/RPBS	 0.027	 0.017	 0.015
	SURVEY	 0.000	 0.001	 0.001
PROTON PUMP INHIBITORS
ESOMEPRAZOLE
A02BC05	PBS/RPBS	 0.000	 1.728	 7.352
	SURVEY	 0.000	 0.006	 0.017
LANSOPRAZOLE
A02BC03	PBS/RPBS	 3.564	 4.263	 4.156
	SURVEY	 0.010	 0.011	 0.009
OMEPRAZOLE
A02BC01	PBS/RPBS	17.560	23.310	21.665
	SURVEY	 0.080	 0.056	 0.052
PANTOPRAZOLE
A02BC02	PBS/RPBS	 5.491	 8.651	 9.041
	SURVEY	 0.009	 0.014	 0.011
RABEPRAZOLE
A02BC04	PBS/RPBS	 0.166	 1.652	 3.376
	SURVEY	 0.001	 0.004	 0.006
OTHER DRUGS FOR PEPTIC ULCER AND GORD
BISMUTH SUBCITRATE
A02BX05	PBS/RPBS	 0.006	 0.000	 0.000
	SURVEY	 0.000	 0.000	 0.000
SUCRALFATE
A02BX02	PBS/RPBS	 0.065	 0.055	 0.045
	SURVEY	 0.000	 0.000	 0.008
ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
DRUGS FOR FUNCTIONAL BOWEL DISORDERS
SYNT ANTICHOLIN,ESTERS WITH TERTIARY AMINO GROUP
MEBEVERINE HYDROCHLORIDE
A03AA04	PBS/RPBS	 0.066	 0.065	 0.061
	SURVEY	 0.407	 0.365	 0.359
SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMP
PROPANTHELINE
A03AB05	PBS/RPBS	 0.251	 0.223	 0.201
	SURVEY	 0.051	 0.041	 0.020
PAPAVERINE AND DERIVATIVES
PAPAVERINE
PAPAVERINE
A03AD01	SURVEY	 0.057	 0.000	 0.000
BELLADONNA AND DERIVATIVES, PLAIN
BELLADONNA ALKALOIDS, TERTIARY AMINES
ATROPINE
A03BA01	PBS/RPBS	 0.008	 0.007	 0.008
	SURVEY	 0.004	 0.003	 0.003
BELLADONNA ALKALOIDS SEMISYNT,QUATER AMMONIUM COMP
HYOSCINE BUTYLBROMIDE
A03BB01	PBS/RPBS	 0.000	 0.000	 0.000
	SURVEY	 0.047	 0.043	 0.045
PROPULSIVES
PROPULSIVES
CISAPRIDE
A03FA02	PBS/RPBS	 0.660	 0.370	 0.221
	SURVEY	 0.025	 0.019	 0.015
DOMPERIDONE
A03FA03	PBS/RPBS	 0.264	 0.299	 0.333
	SURVEY	 0.091	 0.084	 0.105
METOCLOPRAMIDE HYDROCHLORIDE
A03FA01	PBS/RPBS	 0.589	 0.600	 0.603
	SURVEY	 0.343	 0.310	 0.288
ALIMENTARY TRACT AND METABOLISM
ANTIEMETICS AND ANTINAUSEANTS
ANTIEMETICS AND ANTINAUSEANTS
SEROTONIN (5HT3) ANTAGONISTS
DOLASETRON MESYLATE
A04AA04	PBS/RPBS	 0.007	 0.007	 0.008
	SURVEY	 0.000	 0.000	 0.000
ONDANSETRON
A04AA01	PBS/RPBS	 0.017	 0.018	 0.022
	SURVEY	 0.000	 0.000	 0.000
TROPISETRON
A04AA03	PBS/RPBS	 0.009	 0.011	 0.015
	SURVEY	 0.001	 0.001	 0.000
ALIMENTARY TRACT AND METABOLISM
BILE AND LIVER THERAPY
BILE THERAPY
BILE ACID PREPARATIONS
URSODEOXYCHOLIC ACID
A05AA02	PBS/RPBS	 0.055	 0.080	 0.095
	SURVEY	 0.001	 0.001	 0.001
ALIMENTARY TRACT AND METABOLISM
LAXATIVES
LAXATIVES
SOFTENERS, EMOLLIENTS
DOCUSATE SODIUM
A06AA02	PBS/RPBS	 0.000	 0.006	 0.013
	SURVEY	 0.331	 0.242	 0.194
CONTACT LAXATIVES
BISACODYL
A06AB02	PBS/RPBS	 0.973	 0.933	 0.865
	SURVEY	 0.038	 0.034	 0.036
DOCUSATE SODIUM with BISACODYL
A06AB52	PBS/RPBS	 0.022	 0.021	 0.015
	SURVEY	 0.000	 0.001	 0.000
PHENOLPHTHALEIN with LIQUID PARAFFIN
A06AB04	SURVEY	 0.098	 0.109	 0.105
BULK PRODUCERS
PSYLLIUM HYDROPHILIC MUCILLOID
A06AC01	PBS/RPBS	 0.471	 0.470	 0.442
	SURVEY	 0.053	 0.069	 0.057
OSMOTICALLY ACTING LAXATIVES
LACTULOSE
A06AD11	PBS/RPBS	 2.445	 2.545	 2.594
	SURVEY	 0.217	 0.204	 0.209
LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSE
A06AD11	SURVEY	 0.002	 0.002	 0.003
MACROGAL
A06AD15	PBS/RPBS	 0.000	 0.016	 0.223
	SURVEY	 0.000	 0.003	 0.023
ALIMENTARY TRACT AND METABOLISM
ANTIDIARR.,INTEST. ANTIINFL./ANTIINFECT. AGENTS
INTESTINAL ANTIINFECTIVES
ANTIBIOTICS
NEOMYCIN SULPHATE
A07AA01	PBS/RPBS	 0.000	 0.000	 0.001
	SURVEY	 0.000	 0.000	 0.000
NYSTATIN
A07AA02	PBS/RPBS	 0.113	 0.114	 0.110
	SURVEY	 0.087	 0.071	 0.071
VANCOMYCIN
A07AA09	PBS/RPBS	 0.001	 0.001	 0.000
	SURVEY	 0.000	 0.000	 0.000
INTESTINAL ADSORBENTS
CHARCOAL PREPARATIONS
CHARCOAL
A07BA01	SURVEY	 0.000	 0.000	 0.001
ANTIPROPULSIVES
ANTIPROPULSIVES
DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE
A07DA01	PBS/RPBS	 0.172	 0.173	 0.162
	SURVEY	 0.060	 0.052	 0.048
LOPERAMIDE HYDROCHLORIDE
A07DA03	PBS/RPBS	 0.235	 0.249	 0.257
	SURVEY	 0.057	 0.053	 0.053
INTESTINAL ANTIINFLAMMATORY AGENTS
AMINOSALICYLIC ACID AND SIMILAR AGENTS
MESALAZINE
A07EC02	PBS/RPBS	 0.471	 0.533	 0.664
	SURVEY	 0.004	 0.005	 0.002
OLSALAZINE SODIUM
A07EC03	PBS/RPBS	 0.242	 0.249	 0.235
	SURVEY	 0.000	 0.000	 0.000
SULPHASALAZINE
A07EC01	PBS/RPBS	 1.508	 1.493	 1.490
	SURVEY	 0.003	 0.003	 0.003
ALIMENTARY TRACT AND METABOLISM
ANTIOBESITY PREPARATIONS, EXCL DIET PRODUCTS
ANTIOBESITY PREPARATIONS, EXCL DIET PRODUCTS
CENTRALLY ACTING ANTIOBESITY PRODUCTS
DIETHYLPROPION
A08AA03	SURVEY	 0.234	 0.216	 0.194
PHENTERMINE
A08AA01	SURVEY	 1.590	 1.463	 1.265
SIBUTRAMINE
A08AA10	SURVEY	 0.000	 0.724	 0.811
PERIPHERALLY ACTING ANTIOBESITY PRODUCTS
ORLISTAT
A08AB01	SURVEY	 1.078	 0.791	 0.490
ALIMENTARY TRACT AND METABOLISM
ANTIDIABETIC THERAPY
INSULINS AND ANALOGUES
INSULINS AND ANALOGUES, FAST-ACTING
INSULIN (BEEF)
A10AB02	PBS/RPBS	 0.022	 0.022	 0.017
INSULIN (HUMAN)
A10AB01	PBS/RPBS	 1.896	 1.811	 1.644
	SURVEY	 0.002	 0.005	 0.007
INSULIN ASPART
A10AB05	PBS/RPBS	 0.314	 0.534	 0.875
	SURVEY	 0.000	 0.003	 0.006
INSULIN LISPRO
A10AB04	PBS/RPBS	 1.106	 1.135	 1.062
	SURVEY	 0.004	 0.006	 0.003
INSULINS AND ANALOGUES, INTERMEDIATE-ACTING
INSULIN (BEEF)
A10AC02	PBS/RPBS	 0.038	 0.034	 0.030
INSULIN (HUMAN)
A10AC01	PBS/RPBS	 3.514	 3.587	 3.626
	SURVEY	 0.045	 0.044	 0.060
INSULINS AND ANALOGUES, INTERMEDIATE ACTING COMBINED WITH FAST ACTING
INSULIN (HUMAN)
A10AD01	PBS/RPBS	 4.202	 4.373	 4.252
	SURVEY	 0.026	 0.041	 0.041
INSULIN ASPART/PROTAMINE ASPART
A10AD30	PBS/RPBS	 0.000	 0.106	 0.601
	SURVEY	 0.000	 0.000	 0.000
INSULIN LISPRO
A10AD04	PBS/RPBS	 0.370	 0.482	 0.439
	SURVEY	 0.000	 0.001	 0.001
INSULINS AND ANALOGUES, LONG-ACTING
INSULIN (HUMAN)
A10AE01	PBS/RPBS	 0.181	 0.168	 0.155
	SURVEY	 0.000	 0.001	 0.011
ORAL BLOOD GLUCOSE LOWERING DRUGS
BIGUANIDES
METFORMIN HYDROCHLORIDE
A10BA02	PBS/RPBS	 8.195	 9.323	10.121
	SURVEY	 1.807	 1.820	 1.959
ALIMENTARY TRACT AND METABOLISM
ANTIDIABETIC THERAPY
ORAL BLOOD GLUCOSE LOWERING DRUGS
SULFONAMIDES, UREA DERIVATIVES
GLIBENCLAMIDE
A10BB01	PBS/RPBS	 2.808	 2.407	 2.011
	SURVEY	 0.434	 0.314	 0.243
GLICLAZIDE
A10BB09	PBS/RPBS	 7.078	 6.875	 6.483
	SURVEY	 1.354	 1.080	 0.915
GLIMEPIRIDE
A10BB12	PBS/RPBS	 1.299	 2.517	 3.071
	SURVEY	 0.324	 0.569	 0.658
GLIPIZIDE
A10BB07	PBS/RPBS	 1.298	 1.132	 0.969
	SURVEY	 0.198	 0.135	 0.123
TOLBUTAMIDE
A10BB03	PBS/RPBS	 0.259	 0.103	 0.000
	SURVEY	 0.033	 0.014	 0.001
ALPHA GLUCOSIDASE INHIBITORS
ACARBOSE
A10BF01	PBS/RPBS	 0.292	 0.274	 0.263
	SURVEY	 0.001	 0.003	 0.002
THIAZOLIDINEDIONES
PIOGLITAZONE HYDROCHLORIDE
A10BG03	PBS/RPBS	 0.000	 0.000	 0.015
	SURVEY	 0.000	 0.004	 0.006
ROSIGLITAZONE
A10BG02	PBS/RPBS	 0.000	 0.000	 0.024
	SURVEY	 0.003	 0.007	 0.016
OTHER OTHER BLOOD GLUCOSE LOWERING DRUGS
REPAGLINIDE
A10BX02	SURVEY	 0.022	 0.013	 0.010
ALIMENTARY TRACT AND METABOLISM
VITAMINS
VIT A AND D, INCL COMBINATIONS OF THE TWO
VITAMIN A, PLAIN
VITAMIN A
A11CA01	SURVEY	 0.011	 0.014	 0.013
VITAMIN D AND ANALOGUES
CALCITRIOL
A11CC04	PBS/RPBS	 1.368	 1.045	 0.817
	SURVEY	 0.021	 0.020	 0.013
VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12
THIAMINE (VIT B1), PLAIN
THIAMINE HYDROCHLORIDE
A11DA01	PBS/RPBS	 0.530	 0.531	 0.506
	SURVEY	 0.789	 0.867	 1.098
ASCORBIC ACID (VIT C), INCL COMBINATIONS
ASCORBIC ACID (VIT C), PLAIN
ASCORBIC ACID
A11GA01	PBS/RPBS	 0.005	 0.004	 0.005
	SURVEY	 0.000	 0.002	 0.006
OTHER PLAIN VITAMIN PREPARATIONS
OTHER PLAIN VITAMIN PREPARATIONS
PYRIDOXINE HYDROCHLORIDE
A11HA02	PBS/RPBS	 0.029	 0.028	 0.028
	SURVEY	 0.009	 0.010	 0.012
ALIMENTARY TRACT AND METABOLISM
MINERAL SUPPLEMENTS
CALCIUM
CALCIUM
CALCIUM (DIFFERENT SALTS IN COMBINATION)
A12AA20	SURVEY	 0.010	 0.010	 0.011
CALCIUM CARBONATE
A12AA04	PBS/RPBS	 2.245	 2.478	 2.538
	SURVEY	 0.043	 0.044	 0.050
CALCIUM, COMBINATIONS WITH OTHER DRUGS
CALCIUM CARBONATE with CHOLECALCIFEROL
A12AX	SURVEY	 0.006	 0.008	 0.008
POTASSIUM
POTASSIUM
POTASSIUM CHLORIDE
A12BA01	PBS/RPBS	 2.408	 2.202	 1.992
	SURVEY	 0.103	 0.098	 0.078
OTHER MINERAL SUPPLEMENTS
ZINC
ZINC SULPHATE
A12CB01	SURVEY	 0.001	 0.002	 0.002
SELENIUM
SELENIUM
A12CE01	SURVEY	 0.027	 0.035	 0.042
ALIMENTARY TRACT AND METABOLISM
ANABOLIC AGENTS FOR SYSTEMIC USE
ANABOLIC STEROIDS
ANDROSTAN DERIVATIVES
METHENOLONE
A14AA04	PBS/RPBS	 0.003	 0.002	 0.000
	SURVEY	 0.006	 0.003	 0.000
ESTREN DERIVATIVES
NANDROLONE DECANOATE
A14AB01	PBS/RPBS	 0.241	 0.186	 0.149
	SURVEY	 0.023	 0.022	 0.022
BLOOD AND BLOOD FORMING ORGANS
ANTITHROMBOTIC AGENTS
ANTITHROMBOTIC AGENTS
VITAMIN K ANTAGONISTS
PHENINDIONE
B01AA02	SURVEY	 0.001	 0.001	 0.000
WARFARIN
B01AA03	PBS/RPBS	 3.555	 3.807	 4.094
	SURVEY	 0.725	 0.678	 0.746
HEPARIN GROUP
DALTEPARIN
B01AB04	PBS/RPBS	 0.034	 0.048	 0.058
	SURVEY	 0.002	 0.000	 0.000
ENOXAPARIN
B01AB05	PBS/RPBS	 0.246	 0.470	 0.608
	SURVEY	 0.017	 0.005	 0.004
HEPARIN CALCIUM
B01AB01	PBS/RPBS	 0.016	 0.016	 0.012
	SURVEY	 0.000	 0.000	 0.001
HEPARIN SODIUM
B01AB01	PBS/RPBS	 0.033	 0.027	 0.022
	SURVEY	 0.000	 0.000	 0.000
PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN
ASPIRIN
B01AC06	PBS/RPBS	13.065	14.542	16.199
	SURVEY	 1.010	 1.096	 1.070
CLOPIDOGREL
B01AC04	PBS/RPBS	 2.687	 4.135	 5.670
	SURVEY	 0.006	 0.013	 0.013
DIPYRIDAMOLE
B01AC07	PBS/RPBS	 0.615	 0.487	 0.395
	SURVEY	 0.007	 0.006	 0.008
DIPYRIDAMOLE with ASPRIN
B01AC30	PBS/RPBS	 0.999	 1.440	 1.644
	SURVEY	 0.001	 0.002	 0.003
TICLOPIDINE HYDROCHLORIDE
B01AC05	PBS/RPBS	 0.057	 0.040	 0.030
	SURVEY	 0.000	 0.000	 0.000
BLOOD AND BLOOD FORMING ORGANS
ANTIHAEMORRHAGICS
ANTIFIBRINOLYTICS
AMINO ACIDS
TRANEXAMIC ACID
B02AA02	PBS/RPBS	 0.069	 0.071	 0.079
	SURVEY	 0.001	 0.000	 0.001
VITAMIN K AND OTHER HAEMOSTATICS
VITAMIN K
MENAPHTHONE
B02BA02	SURVEY	 0.014	 0.012	 0.009
PHYTOMENADIONE
B02BA01	SURVEY	 0.004	 0.003	 0.004
BLOOD AND BLOOD FORMING ORGANS
ANTIANAEMIC PREPARATIONS
IRON PREPARATIONS
IRON BIVALENT, ORAL PREPARATIONS
FERROUS GLUCONATE
B03AA03	PBS/RPBS	 0.029	 0.031	 0.017
	SURVEY	 0.002	 0.002	 0.002
FERROUS SULPHATE DRIED
B03AA07	PBS/RPBS	 0.070	 0.000	 0.000
	SURVEY	 0.883	 0.778	 0.710
IRON TRIVALENT, PARENTERAL PREPARATIONS
IRON POLYMALTOSE COMPLEX
B03AC03	PBS/RPBS	 0.022	 0.024	 0.023
	SURVEY	 0.000	 0.000	 0.000
VITAMIN B12 AND FOLIC ACID
VITAMIN B12 (CYANOCOBALAMIN AND DERIVATIVES)
CYANOCOBALAMIN
B03BA01	SURVEY	 0.085	 0.109	 0.094
HYDROXOCOBALAMIN
B03BA03	PBS/RPBS	 3.826	 4.103	 4.370
	SURVEY	 0.415	 0.354	 0.351
FOLIC ACID AND DERIVATIVES
FOLIC ACID
B03BB01	SURVEY	 0.000	 0.000	 0.014
OTHER ANTIANAEMIC PREPARATIONS
OTHER ANTIANAEMIC PREPARATIONS
DARBEPOETIN ALPHA
B03XA02	PBS/RPBS	 0.000	 0.010	 0.058
	SURVEY	 0.000	 0.000	 0.000
ERYTHROPOIETIN
B03XA01	PBS/RPBS	 0.037	 0.047	 0.036
	SURVEY	 0.001	 0.002	 0.000
CARDIOVASCULAR SYSTEM
CARDIAC THERAPY
CARDIAC GLYCOSIDES
DIGITALIS GLYCOSIDES
DIGOXIN
C01AA05	PBS/RPBS	 5.857	 5.525	 5.119
	SURVEY	 0.669	 0.538	 0.480
ANTIARRHYTHMICS, CLASS I AND III
ANTIARRHYTHMICS, CLASS IA
DISOPYRAMIDE
C01BA03	PBS/RPBS	 0.080	 0.070	 0.062
	SURVEY	 0.000	 0.000	 0.000
QUINIDINE
C01BA01	PBS/RPBS	 0.065	 0.054	 0.048
	SURVEY	 0.000	 0.002	 0.000
ANTIARRHYTHMICS, CLASS IB
LIGNOCAINE HYDROCHLORIDE
C01BB01	PBS/RPBS	 0.000	 0.000	 0.000
	SURVEY	 0.000	 0.000	 0.001
MEXILETINE HYDROCHLORIDE
C01BB02	PBS/RPBS	 0.024	 0.022	 0.019
	SURVEY	 0.000	 0.001	 0.000
ANTIARRHYTHMICS, CLASS IC
FLECAINIDE ACETATE
C01BC04	PBS/RPBS	 0.391	 0.413	 0.422
	SURVEY	 0.000	 0.000	 0.001
ANTIARRHYTHMICS, CLASS III
AMIODARONE HYDROCHLORIDE
C01BD01	PBS/RPBS	 1.604	 1.686	 1.616
	SURVEY	 0.012	 0.016	 0.014
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
ADRENERGIC AGENTS
ADRENALINE
C01CA24	PBS/RPBS	 0.038	 0.037	 0.035
	SURVEY	 0.009	 0.005	 0.003
CARDIOVASCULAR SYSTEM
CARDIAC THERAPY
VASODILATORS USED IN CARDIC DISEASES
ORGANIC NITRATES
GLYCERYL TRINITRATE
C01DA02	PBS/RPBS	 6.345	 6.101	 5.920
	SURVEY	 0.173	 0.124	 0.116
ISOSORBIDE DINITRATE
C01DA08	PBS/RPBS	 0.364	 0.314	 0.261
	SURVEY	 0.014	 0.017	 0.012
ISOSORBIDE MONONITRATE
C01DA14	PBS/RPBS	10.576	10.498	 9.995
	SURVEY	 0.370	 0.287	 0.271
OTHER VASODILATORS USED IN CARDIAC DISEASES
NICORANDIL
C01DX16	PBS/RPBS	 0.239	 0.006	 0.005
	SURVEY	 0.011	 0.000	 0.000
CARDIOVASCULAR SYSTEM
ANTIHYPERTENSIVES
ANTIADRENERGIC AGENTS, CENTRALLY ACTING
METHYLDOPA
METHYLDOPA
C02AB01	PBS/RPBS	 0.609	 0.561	 0.521
	SURVEY	 0.108	 0.091	 0.086
IMIDAZOLINE RECEPTOR AGONISTS
CLONIDINE
C02AC01	PBS/RPBS	 0.494	 0.480	 0.474
	SURVEY	 0.001	 0.002	 0.002
ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
ALPHA - ADRENOCEPTOR BLOCKING AGENTS
PRAZOSIN HYDROCHLORIDE
C02CA01	PBS/RPBS	 3.770	 3.625	 3.461
	SURVEY	 0.308	 0.232	 0.226
ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
HYDRAZINOPHTHALAZINE DERIVATIVES
HYDRALAZINE HYDROCHLORIDE
C02DB02	PBS/RPBS	 0.292	 0.303	 0.308
	SURVEY	 0.046	 0.044	 0.040
PYRIMIDINE DERIVATIVES
MINOXIDIL
C02DC01	PBS/RPBS	 0.029	 0.029	 0.029
	SURVEY	 0.001	 0.001	 0.003
CARDIOVASCULAR SYSTEM
DIURETICS
LOW-CEILING DIURETICS, THIAZIDES
THIAZIDES, PLAIN
BENDROFLUAZIDE
C03AA01	PBS/RPBS	 2.483	 2.349	 2.597
	SURVEY	 0.643	 0.620	 0.679
HYDROCHLOROTHIAZIDE
C03AA03	PBS/RPBS	 2.365	 1.712	 0.183
	SURVEY	 0.607	 0.487	 0.051
LOW-CEILING DIURETICS, EXCL THIAZIDES
SULFONAMIDES, PLAIN
CHLORTHALIDONE
C03BA04	PBS/RPBS	 0.419	 0.377	 0.473
	SURVEY	 0.092	 0.067	 0.097
INDAPAMIDE
C03BA11	PBS/RPBS	 7.486	 6.611	 6.148
	SURVEY	 1.851	 1.431	 1.387
HIGH-CEILING DIURETICS
SULFONAMIDES, PLAIN
BUMETANIDE
C03CA02	PBS/RPBS	 0.655	 0.615	 0.166
	SURVEY	 0.104	 0.078	 0.211
FRUSEMIDE
C03CA01	PBS/RPBS	19.889	19.653	19.207
	SURVEY	 1.548	 1.348	 1.170
ARYLOXYACETIC ACID DERIVATIVES
ETHACRYNIC ACID
C03CC01	PBS/RPBS	 0.054	 0.053	 0.048
	SURVEY	 0.000	 0.000	 0.002
POTASSIUM-SPARING AGENTS
ALDOSTERONE ANTAGONISTS
SPIRONOLACTONE
C03DA01	PBS/RPBS	 2.076	 2.164	 2.180
	SURVEY	 0.119	 0.113	 0.127
OTHER POTASSIUM-SPARING AGENTS
AMILORIDE HYDROCHLORIDE
C03DB01	PBS/RPBS	 0.343	 0.298	 0.251
	SURVEY	 0.034	 0.028	 0.036
CARDIOVASCULAR SYSTEM
DIURETICS
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
LOW-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS
HYDROCHLOROTHIAZIDE with AMILORIDE HYDROCHLORIDE
C03EA01	PBS/RPBS	 6.292	 5.574	 5.153
	SURVEY	 1.827	 1.396	 1.336
HYDROCHLOROTHIAZIDE with TRIAMTERENE
C03EA01	PBS/RPBS	 1.274	 1.076	 0.921
	SURVEY	 0.303	 0.223	 0.214
CARDIOVASCULAR SYSTEM
PERIPHERAL VASODILATORS
PERIPHERAL VASODILATORS
PURINE DERIVATIVES
OXPENTIFYLLINE
C04AD03	SURVEY	 0.027	 0.020	 0.009
OTHER PERIPHERAL VASODILATORS
PHENOXYBENZAMINE HYDROCHLORIDE
C04AX02	PBS/RPBS	 0.016	 0.014	 0.015
	SURVEY	 0.000	 0.001	 0.001
CARDIOVASCULAR SYSTEM
BETA BLOCKING AGENTS
BETA BLOCKING AGENTS, PLAIN
BETA BLOCKING AGENTS, PLAIN, NON-SELECTIVE
OXPRENOLOL HYDROCHLORIDE
C07AA02	PBS/RPBS	 0.058	 0.052	 0.045
	SURVEY	 0.020	 0.011	 0.011
PINDOLOL
C07AA03	PBS/RPBS	 0.509	 0.459	 0.404
	SURVEY	 0.067	 0.055	 0.046
PROPRANOLOL HYDROCHLORIDE
C07AA05	PBS/RPBS	 1.219	 1.177	 1.110
	SURVEY	 0.518	 0.446	 0.421
SOTALOL HYDROCHLORIDE
C07AA07	PBS/RPBS	 2.238	 2.264	 2.226
	SURVEY	 0.072	 0.106	 0.146
BETA BLOCKING AGENTS, PLAIN, SELECTIVE
ATENOLOL
C07AB03	PBS/RPBS	 8.617	 9.111	 9.428
	SURVEY	 2.518	 2.462	 2.447
BISOPROLOL
C07AB07	PBS/RPBS	 0.000	 0.001	 0.053
	SURVEY	 0.000	 0.000	 0.000
METOPROLOL TARTRATE
C07AB02	PBS/RPBS	 4.977	 5.185	 5.292
	SURVEY	 1.110	 1.055	 1.016
ALPHA- AND BETA- ADRENOCEPTOR BLOCKING AGENTS
CARVEDILOL
C07AG02	PBS/RPBS	 0.739	 1.032	 1.330
	SURVEY	 0.000	 0.003	 0.004
LABETALOL HYDROCHLORIDE
C07AG01	PBS/RPBS	 0.117	 0.110	 0.105
	SURVEY	 0.043	 0.044	 0.047
CARDIOVASCULAR SYSTEM
CALCIUM CHANNEL BLOCKERS
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
DIHYDROPYRIDINE DERIVATIVES
AMLODIPINE BESYLATE
C08CA01	PBS/RPBS	14.891	15.209	15.173
	SURVEY	 1.280	 1.125	 1.022
FELODIPINE
C08CA02	PBS/RPBS	10.547	 9.987	 9.406
	SURVEY	 0.700	 0.543	 0.502
LERCANIPIDINE
C08CA13	PBS/RPBS	 0.048	 1.204	 2.626
	SURVEY	 0.001	 0.002	 0.007
NIFEDIPINE
C08CA05	PBS/RPBS	 6.864	 6.539	 6.129
	SURVEY	 0.026	 0.029	 0.092
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
PHENYLALKYLAMINE DERIVATIVES
VERAPAMIL HYDROCHLORIDE
C08DA01	PBS/RPBS	 5.592	 5.230	 4.873
	SURVEY	 1.251	 0.947	 0.859
BENZOTHIAZEPINE DERIVATIVES
DILTIAZEM HYDROCHLORIDE
C08DB01	PBS/RPBS	52.513	44.157	38.171
	SURVEY	 0.055	 0.172	 0.196
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
PERHEXILINE MALEATE
C08EX02	PBS/RPBS	 0.246	 0.248	 0.243
	SURVEY	 0.000	 0.002	 0.002
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, PLAIN
CONVERTING ENZYME BLOCKERS
CAPTOPRIL
C09AA01	PBS/RPBS	 4.399	 3.344	 2.514
	SURVEY	 0.010	 0.013	 0.009
ENALAPRIL MALEATE
C09AA02	PBS/RPBS	12.746	10.506	 8.912
	SURVEY	 0.373	 0.567	 0.460
FOSINOPRIL
C09AA09	PBS/RPBS	 2.967	 2.728	 2.557
	SURVEY	 0.238	 0.190	 0.155
LISINOPRIL
C09AA03	PBS/RPBS	 8.899	 8.251	 7.499
	SURVEY	 0.161	 0.144	 0.136
PERINDOPRIL
C09AA04	PBS/RPBS	 8.865	 9.194	 9.579
	SURVEY	 0.378	 0.391	 0.450
QUINAPRIL
C09AA06	PBS/RPBS	 4.017	 3.717	 3.128
	SURVEY	 0.041	 0.034	 0.202
RAMIPRIL
C09AA05	PBS/RPBS	16.369	23.380	29.038
	SURVEY	 0.257	 0.554	 0.558
TRANDOLAPRIL
C09AA10	PBS/RPBS	 3.167	 2.448	 2.236
	SURVEY	 0.066	 0.603	 0.540
ACE INHIBITORS, COMBINATIONS
ANGIOTENSIN-CONVERTING ENZYME BLOCKERS AND DIURETICS
ENALAPRIL and HYDROCHLOROTHIAZIDE
C09BA02	PBS/RPBS	 0.533	 1.135	 1.403
	SURVEY	 0.002	 0.001	 0.004
FOSINOPRIL with HYDROCHLOROTHIAZIDE
C09BA09	PBS/RPBS	 2.397	 2.921	 3.059
	SURVEY	 0.000	 0.003	 0.085
PERINDOPRIL and INDAPAMIDE
C09BA04	PBS/RPBS	 2.200	 4.444	 5.956
	SURVEY	 0.002	 0.009	 0.014
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
ANGIOTENSIN II ANTAGONISTS
ANGIOTENSIN II ANTAGONISTS, PLAIN
CANDESARTAN
C09CA06	PBS/RPBS	 4.010	 4.925	 5.455
	SURVEY	 0.039	 0.048	 0.531
EPROSARTAN
C09CA02	PBS/RPBS	 0.302	 0.422	 0.492
	SURVEY	 0.000	 0.003	 0.003
IRBESARTAN
C09CA04	PBS/RPBS	15.138	17.197	18.845
	SURVEY	 0.010	 0.025	 0.169
LOSARTAN
C09CA01	SURVEY	 0.020	 0.023	 0.020
TELMISARTAN
C09CA07	PBS/RPBS	 4.010	 4.978	 5.556
	SURVEY	 0.011	 0.010	 0.013
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
ANGIOTENSIN II ANTAGONISTS AND DIURETICS
CANDESARTAN with HYDROCHLOROTHIAZIDE
C09DA06	PBS/RPBS	 0.826	 2.818	 4.398
	SURVEY	 0.001	 0.005	 0.004
IRBESARTAN with HYDROCHLOROTHIAZIDE
C09DA04	PBS/RPBS	11.435	15.945	19.243
	SURVEY	 0.006	 0.034	 0.036
CARDIOVASCULAR SYSTEM
SERUM LIPID REDUCING AGENTS
CHOLESTEROL- AND TRIGLYCERIDE REDUCERS
HMG COA REDUCTASE INHIBITORS
ATORVASTATIN
C10AA05	PBS/RPBS	49.794	61.004	72.101
	SURVEY	 0.078	 0.081	 0.114
CERIVASTATIN
C10AA06	PBS/RPBS	 1.964	 0.000	 0.000
	SURVEY	 0.000	 0.000	 0.000
FLUVASTATIN
C10AA04	PBS/RPBS	 0.637	 0.555	 0.486
	SURVEY	 0.002	 0.001	 0.002
PRAVASTATIN
C10AA03	PBS/RPBS	 9.675	11.894	13.298
	SURVEY	 0.008	 0.022	 0.024
SIMVASTATIN
C10AA01	PBS/RPBS	35.335	40.832	46.945
	SURVEY	 0.030	 0.048	 0.044
FIBRATES
GEMFIBROZIL
C10AB04	PBS/RPBS	 2.024	 1.930	 1.886
	SURVEY	 0.004	 0.002	 0.002
BILE ACID SEQUESTRANTS
CHOLESTYRAMINE
C10AC01	PBS/RPBS	 0.185	 0.197	 0.199
	SURVEY	 0.000	 0.000	 0.001
COLESTIPOL HYDROCHLORIDE
C10AC02	PBS/RPBS	 0.009	 0.009	 0.010
NICOTINIC ACID AND DERIVATIVES
NICOTINIC ACID
C10AD02	PBS/RPBS	 0.047	 0.044	 0.044
	SURVEY	 0.013	 0.013	 0.010
OTHER CHOLESTEROL- AND TRIGLYCERIDE REDUCERS
EZETIMIBE
C10AX09	SURVEY	 0.000	 0.000	 0.003
PROBUCOL
C10AX02	PBS/RPBS	 0.027	 0.002	 0.000
	SURVEY	 0.000	 0.000	 0.000
DERMATOLOGICALS
ANTIFUNGALS FOR DERMATOLOGICAL USE
ANTIFUNGALS FOR SYSTEMIC USE
ANTIFUNGALS FOR SYSTEMIC USE
GRISEOFULVIN
D01BA01	PBS/RPBS	 0.266	 0.258	 0.248
	SURVEY	 0.249	 0.176	 0.158
TERBINAFINE
D01BA02	PBS/RPBS	 0.574	 0.610	 0.580
	SURVEY	 0.034	 0.024	 0.026
DERMATOLOGICALS
ANTIPSORIATICS
ANTIPSORIATICS FOR SYSTEMIC USE
PSORALENS FOR SYSTEMIC USE
METHOXSALEN
D05BA02	SURVEY	 0.003	 0.004	 0.001
RETINOIDS FOR TREATMENT OF PSORIASIS
ACITRETIN
D05BB02	PBS/RPBS	 0.096	 0.091	 0.093
	SURVEY	 0.014	 0.002	 0.000
DERMATOLOGICALS
ANTI-ACNE PREPARATIONS
ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE
RETINOIDS FOR TREATMENT OF ACNE
ISOTRETINOIN
D10BA01	PBS/RPBS	 1.112	 0.876	 0.732
	SURVEY	 0.010	 0.011	 0.008
GENITO URINARY SYSTEM AND SEX HORMONES
GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.
ANTIBIOTICS
CLINDAMYCIN
G01AA10	SURVEY	 0.013	 0.012	 0.013
NYSTATIN
G01AA01	PBS/RPBS	 0.001	 0.002	 0.002
	SURVEY	 0.072	 0.070	 0.062
IMIDAZOLE DERIVATIVES
CLOTRIMAZOLE
G01AF02	PBS/RPBS	 0.001	 0.001	 0.001
	SURVEY	 0.114	 0.115	 0.111
ECONAZOLE NITRATE
G01AF05	SURVEY	 0.007	 0.005	 0.004
MICONAZOLE NITRATE
G01AF04	PBS/RPBS	 0.000	 0.000	 0.000
	SURVEY	 0.023	 0.015	 0.010
GENITO URINARY SYSTEM AND SEX HORMONES
OTHER GYNAECOLOGICALS
OXYTOCICS
PROSTAGLANDINS
DINOPROSTONE
G02AD02	SURVEY	 0.001	 0.001	 0.000
OTHER GYNAECOLOGICALS
PROLACTIN INHIBITORS
BROMOCRIPTINE MESYLATE
G02CB01	PBS/RPBS	 0.007	 0.006	 0.004
	SURVEY	 0.006	 0.006	 0.005
CABERGOLINE
G02CB03	PBS/RPBS	 0.029	 0.031	 0.034
	SURVEY	 0.001	 0.001	 0.000
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
PROGESTOGENS
ETONOGESTREL
G03AC08	PBS/RPBS	 5.858	13.869	 7.749
	SURVEY	 0.007	 0.036	 0.023
LEVONORGESTREL
G03AC03	PBS/RPBS	 0.827	 0.761	 0.651
	SURVEY	 1.736	 1.452	 1.232
MEDROXYPROGESTERONE
G03AC06	PBS/RPBS	 1.977	 1.714	 1.612
	SURVEY	 1.584	 1.204	 1.165
ANDROGENS
3-OXOANDROSTEN (4) DERIVATIVES
FLUOXYMESTERONE
G03BA01	SURVEY	 0.002	 0.000	 0.000
TESTOSTERONE
G03BA03	PBS/RPBS	 0.405	 0.435	 0.461
	SURVEY	 0.108	 0.108	 0.100
5-ANDROSTANON (3) DERIVATIVES
MESTEROLONE
G03BB01	SURVEY	 0.005	 0.002	 0.002
ESTROGENS
NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN
OESTRADIOL
G03CA03	PBS/RPBS	 3.616	 3.155	 2.558
	SURVEY	 2.695	 2.178	 1.789
OESTRADIOL VALERATE
G03CA03	PBS/RPBS	 0.851	 0.722	 0.552
	SURVEY	 0.599	 0.437	 0.349
OESTRIOL
G03CA04	PBS/RPBS	 2.326	 2.377	 2.340
	SURVEY	 0.781	 0.743	 0.750
OESTROGENS CONJUGATED
G03CA57	PBS/RPBS	 5.770	 4.575	 3.187
	SURVEY	 3.413	 2.711	 1.941
OESTRONE
G03CA07	PBS/RPBS	 1.714	 1.361	 0.936
	SURVEY	 1.204	 0.911	 0.610
SYNTHETIC ESTROGENS, PLAIN
DIENOESTROL
G03CB01	SURVEY	 0.011	 0.000	 0.000
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
PROGESTOGENS
PREGNEN (4) DERIVATIVES
MEDROXYPROGESTERONE
G03DA02	PBS/RPBS	 4.403	 3.187	 1.969
	SURVEY	 2.226	 1.418	 0.883
PREGNADIEN DERIVATIVES
DYDROGESTERONE
G03DB01	PBS/RPBS	 0.048	 0.036	 0.030
	SURVEY	 0.096	 0.068	 0.051
ESTREN DERIVATIVES
NORETHISTERONE
G03DC02	PBS/RPBS	 1.150	 0.991	 0.848
	SURVEY	 0.007	 0.005	 0.005
TIBOLONE
G03DC05	SURVEY	 0.577	 0.934	 1.206
PROGESTOGENS AND ESTROGENS IN COMBINATION
PROGESTOGENS AND ESTROGENS, FIXED COMBINATIONS
MEDROXYPROGESTERONE AND ESTROGEN
G03FA12	PBS/RPBS	 2.260	 1.827	 1.133
	SURVEY	 2.024	 1.643	 0.995
NORETHISTERONE AND ESTROGEN
G03FA01	PBS/RPBS	 0.512	 0.424	 0.297
	SURVEY	 0.614	 0.486	 0.342
PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS
DYDROGESTERONE AND ESTROGEN
G03FB08	PBS/RPBS	 0.013	 0.012	 0.009
	SURVEY	 0.027	 0.026	 0.020
MEDROXYPROGESTERONE AND ESTROGEN
G03FB06	PBS/RPBS	 0.259	 0.195	 0.110
	SURVEY	 0.396	 0.298	 0.190
OESTRADIOL with NORETHISTERONE ACETATE
G03FB05	PBS/RPBS	 1.173	 0.963	 0.681
	SURVEY	 1.694	 1.243	 0.930
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
GONADOTROPHINS AND OTHER OVULATION STIMULANTS
GONADOTROPHINS
FOLLITROPIN ALFA
G03GA05	PBS/RPBS	 0.007	 0.005	 0.004
	SURVEY	 0.000	 0.000	 0.000
FOLLITROPIN BETA
G03GA06	PBS/RPBS	 0.004	 0.004	 0.006
	SURVEY	 0.000	 0.000	 0.000
HUMAN CHORIONIC GONADOTROPHIN
G03GA01	PBS/RPBS	 0.022	 0.027	 0.023
	SURVEY	 0.020	 0.019	 0.013
HUMAN MENOPAUSAL GONADOTROPHIN
G03GA02	PBS/RPBS	 0.001	 0.000	 0.000
OVULATION STIMULANTS, SYNTHETIC
CLOMIPHENE CITRATE
G03GB02	PBS/RPBS	 0.306	 0.297	 0.298
	SURVEY	 0.001	 0.003	 0.009
ANTIANDROGENS
ANTIANDROGENS, PLAIN PREPARATIONS
CYPROTERONE ACETATE
G03HA01	PBS/RPBS	 0.552	 0.548	 0.540
	SURVEY	 0.025	 0.006	 0.007
OTHER SEX HORM. MODULATORS OF THE GENITAL SYSTEM
ANTIGONADOTROPINS AND SIMILAR AGENTS
DANAZOL
G03XA01	PBS/RPBS	 0.027	 0.023	 0.019
	SURVEY	 0.001	 0.001	 0.000
GESTRINONE
G03XA02	PBS/RPBS	 0.005	 0.004	 0.003

RALOXIFENE
G03XC01	PBS/RPBS	 1.102	 1.305	 1.381
	SURVEY	 0.055	 0.061	 0.059
GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
OTHER UROLOGICALS, INCL ANTISPASMODICS
ACIDIFIERS
AMMONIUM CHLORIDE
G04BA01	PBS/RPBS	 0.004	 0.004	 0.004
	SURVEY	 0.000	 0.000	 0.000
URINARY ANTISPASMODICS
OXYBUTYNIN
G04BD04	PBS/RPBS	 0.688	 0.766	 0.799
	SURVEY	 0.118	 0.115	 0.119
DRUGS USED IN ERECTILE DYSFUNCTION
ALPROSTADIL
G04BE01	PBS/RPBS	 0.065	 0.056	 0.011
	SURVEY	 0.000	 0.031	 0.058
SILDENAFIL
G04BE03	PBS/RPBS	 0.022	 0.026	 0.028
	SURVEY	 0.375	 0.407	 0.333
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
ALPHA-ADRENORECEPTOR ANTAGONISTS
TAMSULOSIN
G04CA02	PBS/RPBS	 0.018	 0.045	 0.070
	SURVEY	 0.096	 0.169	 0.253
TERAZOSIN
G04CA03	PBS/RPBS	 0.010	 0.009	 0.007
	SURVEY	 0.037	 0.022	 0.023
TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS
FINASTERIDE
G04CB01	PBS/RPBS	 0.044	 0.048	 0.049
	SURVEY	 0.082	 0.069	 0.076
SYSTEMIC HORMONAL PREP,EXCL SEX HORMONES
PITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUES
ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
ACTH
TETRACOSACTRIN
H01AA02	PBS/RPBS	 0.001	 0.001	 0.001
	SURVEY	 0.000	 0.000	 0.000
POSTERIOR PITUITARY LOBE HORMONES
VASOPRESSIN AND ANALOGUES
DESMOPRESSIN
H01BA02	PBS/RPBS	 0.231	 0.282	 0.280
	SURVEY	 0.004	 0.003	 0.006
HYPOTHALAMIC HORMONES
GONADOTROPHIN-RELEASING HORMONES
NAFARELIN
H01CA02	PBS/RPBS	 0.010	 0.010	 0.011
	SURVEY	 0.007	 0.014	 0.007
ANTIGROWTH HORMONE
OCTREOTIDE
H01CB02	PBS/RPBS	 0.000	 0.000	 0.000
	SURVEY	 0.001	 0.000	 0.000
SYSTEMIC HORMONAL PREP,EXCL SEX HORMONES
CORTICOSTEROIDS FOR SYSTEMIC USE
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
MINERALOCORTICOIDS
FLUDROCORTISONE ACETATE
H02AA02	PBS/RPBS	 0.400	 0.411	 0.422
	SURVEY	 0.119	 0.141	 0.143
GLUCOCORTICOIDS
BETAMETHASONE
H02AB01	PBS/RPBS	 0.166	 0.164	 0.167
	SURVEY	 0.005	 0.005	 0.005
BUDESONIDE
H02AB16	SURVEY	 0.008	 0.004	 0.007
CORTISONE
H02AB10	PBS/RPBS	 0.142	 0.139	 0.138
	SURVEY	 0.059	 0.052	 0.062
DEXAMETHASONE
H02AB02	PBS/RPBS	 0.662	 0.681	 0.736
	SURVEY	 0.151	 0.164	 0.208
HYDROCORTISONE
H02AB09	PBS/RPBS	 0.105	 0.111	 0.117
	SURVEY	 0.033	 0.025	 0.034
METHYLPREDNISOLONE
H02AB04	PBS/RPBS	 0.085	 0.079	 0.076
	SURVEY	 0.022	 0.016	 0.015
PREDNISOLONE
H02AB06	PBS/RPBS	 4.799	 4.906	 4.906
	SURVEY	 2.009	 1.941	 2.065
PREDNISONE
H02AB07	PBS/RPBS	 2.517	 2.434	 2.342
	SURVEY	 1.510	 1.225	 1.087
TRIAMCINOLONE ACETONIDE
H02AB08	PBS/RPBS	 0.029	 0.027	 0.029
	SURVEY	 0.003	 0.006	 0.003
SYSTEMIC HORMONAL PREP,EXCL SEX HORMONES
THYROID THERAPY
THYROID PREPARATIONS
THYROID HORMONES
LIOTHYRONINE
H03AA02	PBS/RPBS	 0.033	 0.040	 0.042
	SURVEY	 0.005	 0.003	 0.004
THYROXINE SODIUM
H03AA01	PBS/RPBS	 8.989	 9.535	 9.812
	SURVEY	 4.619	 4.850	 4.889
ANTITHYROID PREPARATIONS
THIOURACILS
PROPYLTHIOURACIL
H03BA02	PBS/RPBS	 0.181	 0.183	 0.201
	SURVEY	 0.004	 0.006	 0.004
SULPHUR-CONTAINING IMIDAZOLE DERIVATIVES
CARBIMAZOLE
H03BB01	PBS/RPBS	 0.452	 0.488	 0.532
	SURVEY	 0.032	 0.026	 0.028
SYSTEMIC HORMONAL PREP,EXCL SEX HORMONES
PANCREATIC HORMONES
GLYCOGENOLYTIC HORMONES
GLYCOGENOLYTIC HORMONES
GLUCAGON HYDROCHLORIDE
H04AA01	PBS/RPBS	 0.004	 0.005	 0.005
	SURVEY	 0.000	 0.000	 0.000
SYSTEMIC HORMONAL PREP,EXCL SEX HORMONES
CALCIUM HOMEOSTASIS
ANTI-PARATHYROID HORMONES
CALCITONIN PREPARATIONS
CALCITONIN (SALMON SYNTHETIC)
H05BA01	PBS/RPBS	 0.003	 0.002	 0.001
	SURVEY	 0.000	 0.000	 0.000
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
TETRACYCLINES
TETRACYCLINES
DEMECLOCYCLINE HYDROCHLORIDE
J01AA01	PBS/RPBS	 0.006	 0.007	 0.009
	SURVEY	 0.000	 0.000	 0.000
DOXYCYCLINE
J01AA02	PBS/RPBS	 1.417	 1.342	 1.271
	SURVEY	 1.507	 1.263	 1.145
MINOCYCLINE
J01AA08	PBS/RPBS	 0.396	 0.374	 0.351
	SURVEY	 0.549	 0.466	 0.455
TETRACYCLINE
J01AA07	PBS/RPBS	 0.144	 0.137	 0.129
	SURVEY	 0.128	 0.097	 0.087
TETRACYCLINE with NYSTATIN
J01AA20	SURVEY	 0.001	 0.000	 0.000
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
PENICILLINS WITH EXTENDED SPECTRUM
AMOXYCILLIN
J01CA04	PBS/RPBS	 2.510	 2.479	 2.557
	SURVEY	 2.288	 2.127	 2.147
AMPICILLIN
J01CA01	PBS/RPBS	 0.007	 0.006	 0.006
	SURVEY	 0.001	 0.001	 0.001
BETA-LACTAMASE SENSITIVE PENICILLINS
BENZYLPENICILLIN
J01CE01	PBS/RPBS	 0.005	 0.005	 0.003
	SURVEY	 0.000	 0.000	 0.000
PHENOXYMETHYLPENICILLIN
J01CE02	PBS/RPBS	 0.286	 0.268	 0.242
	SURVEY	 0.417	 0.368	 0.325
PROCAINE PENICILLIN
J01CE09	PBS/RPBS	 0.014	 0.011	 0.010
	SURVEY	 0.001	 0.000	 0.000
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
BETA-LACTAMASE RESISTANT PENICILLINS
DICLOXACILLIN
J01CF01	PBS/RPBS	 0.209	 0.210	 0.199
	SURVEY	 0.201	 0.169	 0.145
FLUCLOXACILLIN
J01CF05	PBS/RPBS	 0.177	 0.171	 0.173
	SURVEY	 0.136	 0.128	 0.123
COMBINATIONS OF PENICILLINS, INCL.BETA-LACTAMASE INHIBITORS
AMOXYCILLIN with CLAVULANIC ACID
J01CR02	PBS/RPBS	 1.487	 1.479	 1.489
	SURVEY	 1.387	 1.283	 1.231
TICARCILLIN with CLAVULANIC ACID
J01CR03	PBS/RPBS	 0.002	 0.003	 0.004
	SURVEY	 0.000	 0.000	 0.000
OTHER BETA-LACTAM ANTIBACTERIALS
FIRST-GENERATION CEPHALOSPORINS
CEFALEXIN
J01DB01	PBS/RPBS	 1.159	 1.173	 1.214
	SURVEY	 0.801	 0.756	 0.733
CEPHALOTHIN
J01DB03	PBS/RPBS	 0.019	 0.019	 0.018
	SURVEY	 0.001	 0.001	 0.000
CEPHAZOLIN
J01DB04	PBS/RPBS	 0.002	 0.002	 0.005
	SURVEY	 0.000	 0.000	 0.000
SECOND-GENERATION CEPHALOSPORINS
CEFACLOR
J01DC04	PBS/RPBS	 0.470	 0.391	 0.328
	SURVEY	 0.406	 0.305	 0.269
CEFUROXIME
J01DC02	PBS/RPBS	 0.070	 0.053	 0.050
	SURVEY	 0.060	 0.049	 0.044
THIRD-GENERATION CEPHALOSPORINS
CEFOTAXIME
J01DD01	PBS/RPBS	 0.002	 0.002	 0.001
	SURVEY	 0.000	 0.000	 0.000
CEFTRIAXONE
J01DD04	PBS/RPBS	 0.016	 0.017	 0.016
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
SULFONAMIDES AND TRIMETHOPRIM
TRIMETHOPRIM AND DERIVATIVES
TRIMETHOPRIM
J01EA01	PBS/RPBS	 0.329	 0.334	 0.345
	SURVEY	 0.164	 0.157	 0.153
COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVAT
TRIMETHOPRIM with SULPHAMETHOXAZOLE
J01EE01	PBS/RPBS	 0.288	 0.269	 0.260
	SURVEY	 0.209	 0.182	 0.158
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
MACROLIDES
AZITHROMYCIN
J01FA10	PBS/RPBS	 0.007	 0.006	 0.007
	SURVEY	 0.009	 0.011	 0.011
CLARITHROMYCIN
J01FA09	PBS/RPBS	 0.236	 0.281	 0.300
	SURVEY	 0.166	 0.197	 0.232
ERYTHROMYCIN
J01FA01	PBS/RPBS	 0.582	 0.506	 0.458
	SURVEY	 0.575	 0.481	 0.397
ROXITHROMYCIN
J01FA06	PBS/RPBS	 0.967	 0.887	 0.806
	SURVEY	 0.754	 0.637	 0.533
LINCOSAMIDES
CLINDAMYCIN
J01FF01	PBS/RPBS	 0.023	 0.027	 0.032
	SURVEY	 0.017	 0.013	 0.013
AMINOGLYCOSIDE ANTIBACTERIALS
OTHER AMINOGLYCOSIDES
GENTAMICIN SULPHATE
J01GB03	PBS/RPBS	 0.011	 0.011	 0.011
	SURVEY	 0.001	 0.001	 0.001
TOBRAMYCIN
J01GB01	PBS/RPBS	 0.001	 0.002	 0.002
	SURVEY	 0.000	 0.000	 0.000

GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
QUINOLONE ANTIBACTERIALS
FLUOROQUINOLONES
CIPROFLOXACIN
J01MA02	PBS/RPBS	 0.215	 0.209	 0.204
	SURVEY	 0.013	 0.010	 0.015
MOXIFLOXACIN
J01MA14	PBS/RPBS	 0.000	 0.000	 0.000
	SURVEY	 0.000	 0.001	 0.004
NORFLOXACIN
J01MA06	PBS/RPBS	 0.145	 0.142	 0.147
	SURVEY	 0.069	 0.066	 0.065
OTHER ANTIBACTERIALS
GLYCOPEPTIDE ANTIBACTERIALS
VANCOMYCIN
J01XA01	PBS/RPBS	 0.004	 0.006	 0.005
	SURVEY	 0.000	 0.000	 0.000
STEROID ANTIBACTERIALS
FUSIDIC ACID
J01XC01	PBS/RPBS	 0.024	 0.027	 0.030
	SURVEY	 0.000	 0.000	 0.000
IMIDAZOLE DERIVATIVES
METRONIDAZOLE
J01XD01	PBS/RPBS	 0.007	 0.007	 0.007
	SURVEY	 0.000	 0.000	 0.000
NITROFURAN DERIVATIVES
NITROFURANTOIN
J01XE01	PBS/RPBS	 0.233	 0.222	 0.213
	SURVEY	 0.069	 0.053	 0.051
OTHER ANTIBACTERIALS
METHENAMINE
J01XX05	PBS/RPBS	 0.457	 0.460	 0.457
	SURVEY	 0.003	 0.008	 0.006
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIMYCOTICS FOR SYSTEMIC USE
ANTIMYCOTICS FOR SYSTEMIC USE
IMIDAZOLE DERIVATIVES
KETOCONAZOLE
J02AB02	PBS/RPBS	 0.140	 0.128	 0.116
	SURVEY	 0.058	 0.046	 0.045
TRIAZOLE DERIVATIVES
FLUCONAZOLE
J02AC01	PBS/RPBS	 0.039	 0.042	 0.044
	SURVEY	 0.006	 0.005	 0.005
ITRACONAZOLE
J02AC02	PBS/RPBS	 0.022	 0.023	 0.022
	SURVEY	 0.007	 0.004	 0.003
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIMYCOBACTERIALS
DRUGS FOR TREATMENT OF TUBERCULOSIS
ANTIBIOTICS
RIFABUTIN
J04AB04	PBS/RPBS	 0.000	 0.000	 0.000
	SURVEY	 0.000	 0.001	 0.009
RIFAMPICIN
J04AB02	PBS/RPBS	 0.008	 0.007	 0.007
	SURVEY	 0.005	 0.007	 0.006
HYDRAZIDES
ISONIAZID
J04AC01	PBS/RPBS	 0.004	 0.004	 0.004
	SURVEY	 0.003	 0.001	 0.002
OTHER DRUGS FOR TREATMENT OF TUBERCULOSIS
ETHAMBUTOL HYDROCHLORIDE
J04AK02	SURVEY	 0.001	 0.000	 0.001
DRUGS FOR TREATMENT OF LEPRA
DRUGS FOR TREATMENT OF LEPRA
CLOFAZIMINE
J04BA01	SURVEY	 0.000	 0.001	 0.004
DAPSONE
J04BA02	SURVEY	 0.080	 0.032	 0.001
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIVIRALS FOR SYSTEMIC USE
DIRECT ACTING ANTIVIRALS
NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS
ACICLOVIR
J05AB01	PBS/RPBS	 0.049	 0.042	 0.035
	SURVEY	 0.001	 0.001	 0.001
FAMCICLOVIR
J05AB09	PBS/RPBS	 0.157	 0.176	 0.183
	SURVEY	 0.013	 0.003	 0.003
VALACICLOVIR
J05AB11	PBS/RPBS	 0.119	 0.151	 0.175
	SURVEY	 0.003	 0.002	 0.002
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
LAMIVUDINE
J05AF05	PBS/RPBS	 0.003	 0.007	 0.009
	SURVEY	 0.001	 0.000	 0.000
NEURAMINIDASE INHIBITORS
ZANAMIVIR
J05AH01	SURVEY	 0.005	 0.002	 0.002

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONES AND RELATED AGENTS
ESTROGENS
FOSFESTROL
L02AA04	PBS/RPBS	 0.015	 0.015	 0.001
	SURVEY	 0.000	 0.000	 0.000
PROGESTOGENS
MEDROXYPROGESTERONE
L02AB02	PBS/RPBS	 0.015	 0.014	 0.010
	SURVEY	 0.000	 0.000	 0.000
MEGESTROL
L02AB01	PBS/RPBS	 0.014	 0.011	 0.011
	SURVEY	 0.000	 0.000	 0.000
GONADOTROPHIN RELEASING HORMONE ANALOGUES
GOSERELIN
L02AE03	PBS/RPBS	 0.522	 0.540	 0.554
	SURVEY	 0.085	 0.006	 0.002
LEUPRORELIN ACETATE
L02AE02	PBS/RPBS	 0.424	 0.495	 0.555
	SURVEY	 0.119	 0.020	 0.006
HORMONE ANTAGONISTS AND RELATED AGENTS
ANTI-ESTROGENS
TAMOXIFEN
L02BA01	PBS/RPBS	 1.768	 1.763	 1.693
	SURVEY	 0.003	 0.016	 0.014
TOREMIFENE
L02BA02	PBS/RPBS	 0.043	 0.043	 0.040
	SURVEY	 0.000	 0.000	 0.000
ANTI-ANDROGENS
BICALUTAMIDE
L02BB03	PBS/RPBS	 0.098	 0.125	 0.140
	SURVEY	 0.002	 0.001	 0.001
FLUTAMIDE
L02BB01	PBS/RPBS	 0.056	 0.045	 0.037
	SURVEY	 0.000	 0.000	 0.000
NILUTAMIDE
L02BB02	PBS/RPBS	 0.083	 0.071	 0.071
	SURVEY	 0.001	 0.001	 0.000
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONE ANTAGONISTS AND RELATED AGENTS
ENZYME INHIBITORS
AMINOGLUTETHIMIDE
L02BG01	PBS/RPBS	 0.002	 0.002	 0.001
	SURVEY	 0.000	 0.000	 0.000
ANASTROZOLE
L02BG03	PBS/RPBS	 0.077	 0.107	 0.135
	SURVEY	 0.000	 0.001	 0.000
EXEMESTANE
L02BG06	PBS/RPBS	 0.013	 0.024	 0.028
	SURVEY	 0.000	 0.000	 0.000
LETROZOLE
L02BG04	PBS/RPBS	 0.090	 0.111	 0.138
	SURVEY	 0.000	 0.001	 0.005
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSTIMULANTS
CYTOKINES AND IMMUNOMODULATORS
COLONY STIMULATING FACTORS
FILGRASTIM
L03AA02	PBS/RPBS	 0.007	 0.010	 0.005
	SURVEY	 0.092	 0.004	 0.004
PEGFILGRASTIM
L03AA13	PBS/RPBS	 0.000	 0.000	 0.015
	SURVEY	 0.000	 0.000	 0.004
INTERFERONS
INTERFERON BETA-1a
L03AB07	PBS/RPBS	 0.175	 0.242	 0.277
	SURVEY	 0.016	 0.003	 0.002
INTERFERON BETA-1b
L03AB08	PBS/RPBS	 0.121	 0.134	 0.137
	SURVEY	 0.018	 0.002	 0.003
INTERFERON-ALFA-2a
L03AB04	PBS/RPBS	 0.006	 0.007	 0.006
	SURVEY	 0.001	 0.000	 0.000
INTERFERON-ALFA-2b
L03AB05	PBS/RPBS	 0.009	 0.009	 0.008
	SURVEY	 0.000	 0.000	 0.000
OTHER CYTOKINES AND IMMUNOMODULATORS
GLATIRAMER ACETATE
L03AX13	PBS/RPBS	 0.035	 0.044	 0.050
	SURVEY	 0.006	 0.001	 0.000
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSIVE AGENTS
IMMUNOSUPPRESSIVE AGENTS
SELECTIVE IMMUNOSUPPRESSIVE AGENTS
CYCLOSPORIN
L04AA01	PBS/RPBS	 0.010	 0.014	 0.013
	SURVEY	 0.000	 0.000	 0.002
ETANERCEPT
L04AA11	PBS/RPBS	 0.000	 0.000	 0.007
	SURVEY	 0.000	 0.000	 0.000
LEFLUNOMIDE
L04AA13	PBS/RPBS	 0.306	 0.347	 0.383
	SURVEY	 0.002	 0.001	 0.001
MYCOPHENOLIC ACID
L04AA06	PBS/RPBS	 0.001	 0.003	 0.004
	SURVEY	 0.000	 0.000	 0.000
TACROLIMUS
L04AA05	PBS/RPBS	 0.000	 0.000	 0.002
	SURVEY	 0.000	 0.000	 0.000
OTHER IMMUNOSUPPRESSIVE AGENTS
AZATHIOPRINE
L04AX01	PBS/RPBS	 0.410	 0.430	 0.439
	SURVEY	 0.003	 0.001	 0.001
MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES
DICLOFENAC
M01AB05	PBS/RPBS	 3.226	 3.188	 3.105
	SURVEY	 1.981	 1.803	 1.737
DICLOFENAC WITH MISOPROSTOL
M01AB55	PBS/RPBS	 0.018	 0.014	 0.011
	SURVEY	 0.011	 0.007	 0.007
INDOMETHACIN
M01AB01	PBS/RPBS	 0.881	 0.875	 0.855
	SURVEY	 0.528	 0.529	 0.528
KETOROLAC
M01AB15	SURVEY	 0.005	 0.006	 0.006
SULINDAC
M01AB02	PBS/RPBS	 0.140	 0.119	 0.097
	SURVEY	 0.019	 0.018	 0.020
OXICAMS
MELOXICAM
M01AC06	PBS/RPBS	 0.000	 1.497	 3.202
	SURVEY	 0.000	 0.008	 0.022
PIROXICAM
M01AC01	PBS/RPBS	 1.282	 1.121	 0.973
	SURVEY	 0.625	 0.479	 0.444
TENOXICAM
M01AC02	PBS/RPBS	 0.144	 0.092	 0.000
	SURVEY	 0.028	 0.018	 0.000
PROPIONIC ACID DERIVATIVES
IBUPROFEN
M01AE01	PBS/RPBS	 0.990	 0.970	 0.952
	SURVEY	 0.481	 0.450	 0.442
IBUPROFEN with CODEINE
M01AE01	SURVEY	 0.000	 0.000	 0.052
KETOPROFEN
M01AE03	PBS/RPBS	 1.563	 1.342	 1.112
	SURVEY	 0.576	 0.440	 0.392
NAPROXEN
M01AE02	PBS/RPBS	 3.376	 3.135	 2.853
	SURVEY	 2.019	 1.734	 1.672
TIAPROFENIC ACID
M01AE11	PBS/RPBS	 0.168	 0.137	 0.112
	SURVEY	 0.034	 0.033	 0.030
MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
FENAMATES
MEFENAMIC ACID
M01AG01	PBS/RPBS	 0.060	 0.054	 0.051
	SURVEY	 0.033	 0.027	 0.025
COXIBS
CELECOXIB
M01AH01	PBS/RPBS	23.343	16.789	14.930
	SURVEY	 0.160	 0.133	 0.133
ROFECOXIB
M01AH02	PBS/RPBS	 6.375	 9.638	10.762
	SURVEY	 0.034	 0.070	 0.071
SPECIFIC ANTIRHEUMATIC AGENTS
GOLD PREPARATIONS
AURANOFIN
M01CB03	PBS/RPBS	 0.028	 0.025	 0.023
	SURVEY	 0.000	 0.000	 0.000
AUROTHIOGLUCOSE
M01CB04	PBS/RPBS	 0.030	 0.005	 0.000
SODIUM AUROTHIOMALATE
M01CB01	PBS/RPBS	 0.116	 0.126	 0.114
	SURVEY	 0.000	 0.000	 0.000
PENICILLAMINE
PENICILLAMINE
M01CC01	PBS/RPBS	 0.070	 0.060	 0.051
	SURVEY	 0.000	 0.000	 0.000
MUSCULO-SKELETAL SYSTEM
MUSCLE RELAXANTS
MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
ETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES
ORPHENADRINE CITRATE
M03BC01	SURVEY	 0.077	 0.066	 0.059
ORPHENADRINE CITRATE with PARACETAMOL
M03BC51	SURVEY	 0.015	 0.013	 0.008
OTHER CENTRALLY ACTING AGENTS
BACLOFEN
M03BX01	PBS/RPBS	 0.486	 0.502	 0.519
	SURVEY	 0.004	 0.009	 0.011
MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
DANTROLENE AND DERIVATIVES
DANTROLENE SODIUM
M03CA01	PBS/RPBS	 0.031	 0.030	 0.030
	SURVEY	 0.001	 0.000	 0.001
MUSCULO-SKELETAL SYSTEM
ANTIGOUT PREPARATIONS
ANTIGOUT PREPARATIONS
PREPARATIONS INHIBITING URIC ACID PRODUCTION
ALLOPURINOL
M04AA01	PBS/RPBS	 5.156	 5.209	 5.131
	SURVEY	 1.939	 1.870	 1.825
PREPARATIONS INCREASING URIC ACID EXCRETION
PROBENECID
M04AB01	PBS/RPBS	 0.105	 0.115	 0.121
	SURVEY	 0.003	 0.001	 0.002
SULPHINPYRAZONE
M04AB02	PBS/RPBS	 0.035	 0.010	 0.000
	SURVEY	 0.000	 0.006	 0.000
PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM
COLCHICINE
M04AC01	PBS/RPBS	 1.078	 1.103	 1.112
	SURVEY	 0.455	 0.455	 0.415
MUSCULO-SKELETAL SYSTEM
DRUGS FOR TREATMENT OF BONE DISEASES
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
BISPHOSPHONATES
ALENDRONIC ACID
M05BA04	PBS/RPBS	 3.617	 5.974	 7.430
	SURVEY	 0.150	 0.223	 0.299
CLODRONIC ACID
M05BA02	PBS/RPBS	 0.046	 0.071	 0.083
	SURVEY	 0.006	 0.002	 0.000
DISODIUM ETIDRONATE
M05BA01	PBS/RPBS	 0.007	 0.005	 0.003
	SURVEY	 0.002	 0.001	 0.001
DISODIUM PAMIDRONATE
M05BA03	PBS/RPBS	 0.002	 0.002	 0.002
	SURVEY	 0.000	 0.003	 0.000
RISEDRONIC ACID
M05BA07	PBS/RPBS	 0.290	 0.569	 1.319
	SURVEY	 0.007	 0.015	 0.040
TILUDRONIC ACID
M05BA05	PBS/RPBS	 0.012	 0.007	 0.006
NERVOUS SYSTEM
ANALGESICS
OPIOIDS
NATURAL OPIUM ALKALOIDS
CODEINE with ASPIRIN
N02AA59	SURVEY	 0.006	 0.009	 0.003
CODEINE with PARACETAMOL
N02AA59	PBS/RPBS	 4.946	 4.952	 4.917
	SURVEY	 1.695	 1.752	 1.713
HYDROMORPHONE
N02AA03	PBS/RPBS	 0.058	 0.087	 0.070
	SURVEY	 0.015	 0.003	 0.000
MORPHINE
N02AA01	PBS/RPBS	 1.667	 1.691	 1.731
	SURVEY	 0.076	 0.080	 0.128
OXYCODONE
N02AA05	PBS/RPBS	 0.531	 0.710	 0.871
	SURVEY	 0.070	 0.069	 0.062
PHENYLPIPERIDINE DERIVATIVES
FENTANYL
N02AB03	PBS/RPBS	 0.158	 0.195	 0.229
	SURVEY	 0.003	 0.004	 0.002
PETHIDINE HYDROCHLORIDE
N02AB02	PBS/RPBS	 0.015	 0.013	 0.012
	SURVEY	 0.011	 0.011	 0.008
DIPHENYLPROPYLAMINE DERIVATIVES
DEXTROMORAMIDE
N02AC01	SURVEY	 0.002	 0.002	 0.001
DEXTROPROPOXYPHENE NAPSYLATE
N02AC04	PBS/RPBS	 0.049	 0.044	 0.040
	SURVEY	 0.097	 0.070	 0.064
DEXTROPROPOXYPHENE with PARACETAMOL
N02AC54	SURVEY	 0.350	 0.315	 0.293
BENZOMORPHAN DERIVATIVES
PENTAZOCINE
N02AD01	SURVEY	 0.002	 0.002	 0.003
ORIPAVINE DERIVATIVES
BUPRENORPHINE
N02AE01	SURVEY	 0.001	 0.002	 0.001
OTHER OPIOIDS
TRAMADOL
N02AX02	PBS/RPBS	 0.460	 1.569	 2.252
	SURVEY	 0.106	 0.297	 0.356
NERVOUS SYSTEM
ANALGESICS
OTHER ANALGESICS AND ANTIPYRETICS
SALICYLIC ACID DERIVATIVES
ASPIRIN
N02BA01	PBS/RPBS	 0.595	 0.524	 0.454
	SURVEY	 0.025	 0.020	 0.018
CODEINE with ASPIRIN
N02BA51	PBS/RPBS	 0.001	 0.001	 0.000
	SURVEY	 0.045	 0.039	 0.031
DIFLUNISAL
N02BA11	PBS/RPBS	 0.188	 0.154	 0.135
	SURVEY	 0.047	 0.030	 0.031
ANILIDES
CODEINE with PARACETAMOL
N02BE51	PBS/RPBS	 0.027	 0.025	 0.023
	SURVEY	 0.122	 0.107	 0.097
PARACETAMOL
N02BE01	PBS/RPBS	10.668	10.706	10.332
	SURVEY	 0.226	 0.206	 0.169
ANTIMIGRAINE PREPARATIONS
ERGOT ALKALOIDS
DIHYDROERGOTAMINE
N02CA01	PBS/RPBS	 0.002	 0.002	 0.001
	SURVEY	 0.002	 0.001	 0.001
ERGOTAMINE
N02CA02	PBS/RPBS	 0.060	 0.025	 0.000
	SURVEY	 0.042	 0.016	 0.000
METHYSERGIDE
N02CA04	PBS/RPBS	 0.052	 0.049	 0.045
	SURVEY	 0.000	 0.000	 0.000
SELECTIVE 5HT RECEPTOR AGONISTS
NARATRIPTAN
N02CC02	PBS/RPBS	 0.019	 0.021	 0.024
	SURVEY	 0.013	 0.013	 0.017
SUMATRIPTAN
N02CC01	PBS/RPBS	 0.067	 0.075	 0.078
	SURVEY	 0.068	 0.063	 0.064
ZOLMITRIPTAN
N02CC03	PBS/RPBS	 0.033	 0.035	 0.037
	SURVEY	 0.020	 0.017	 0.020
OTHER ANTIMIGRAINE PREPARATIONS
PIZOTIFEN MALATE
N02CX01	PBS/RPBS	 0.469	 0.464	 0.458
	SURVEY	 0.204	 0.172	 0.176
NERVOUS SYSTEM
ANTIEPILEPTICS
ANTIEPILEPTICS
BARBITURATES AND DERIVATIVES
METHYLPHENOBARBITONE
N03AA01	PBS/RPBS	 0.043	 0.028	 0.001
	SURVEY	 0.000	 0.000	 0.007
PHENOBARBITONE
N03AA02	PBS/RPBS	 0.125	 0.122	 0.130
	SURVEY	 0.041	 0.027	 0.037
PRIMIDONE
N03AA03	PBS/RPBS	 0.091	 0.095	 0.104
	SURVEY	 0.034	 0.018	 0.002
HYDANTOIN DERIVATIVES
PHENYTOIN
N03AB02	PBS/RPBS	 2.010	 1.945	 1.881
	SURVEY	 0.015	 0.040	 0.021
SUCCINIMIDE DERIVATIVES
ETHOSUXIMIDE
N03AD01	PBS/RPBS	 0.022	 0.021	 0.019
	SURVEY	 0.000	 0.000	 0.000
BENZODIAZEPINE DERIVATIVES
CLONAZEPAM
N03AE01	PBS/RPBS	 0.206	 0.196	 0.176
	SURVEY	 0.210	 0.180	 0.168
CARBOXAMIDE DERIVATIVES
CARBAMAZEPINE
N03AF01	PBS/RPBS	 2.094	 2.036	 1.974
	SURVEY	 0.047	 0.046	 0.039
OXCARBAZEPINE
N03AF02	PBS/RPBS	 0.000	 0.004	 0.030
	SURVEY	 0.000	 0.000	 0.001
FATTY ACID DERIVATIVES
SODIUM VALPROATE
N03AG01	PBS/RPBS	 2.844	 3.039	 3.214
	SURVEY	 0.031	 0.035	 0.029
TIAGABINE
N03AG06	PBS/RPBS	 0.022	 0.022	 0.020
	SURVEY	 0.000	 0.000	 0.000
VIGABATRIN
N03AG04	PBS/RPBS	 0.101	 0.087	 0.074
	SURVEY	 0.000	 0.000	 0.000
NERVOUS SYSTEM
ANTIEPILEPTICS
ANTIEPILEPTICS
OTHER ANTIEPILEPTICS
GABAPENTIN
N03AX12	PBS/RPBS	 0.230	 0.285	 0.306
	SURVEY	 0.054	 0.096	 0.121
LAMOTRIGINE
N03AX09	PBS/RPBS	 0.561	 0.625	 0.679
	SURVEY	 0.018	 0.008	 0.011
LEVETIRACETAM
N03AX14	PBS/RPBS	 0.000	 0.000	 0.033
SULTHIAME
N03AX03	PBS/RPBS	 0.029	 0.030	 0.028
TOPIRAMATE
N03AX11	PBS/RPBS	 0.164	 0.195	 0.229
	SURVEY	 0.008	 0.007	 0.012
NERVOUS SYSTEM
ANTI-PARKINSON DRUGS
ANTICHOLINERGIC AGENTS
TERTIARY AMINES WITH CARBON CHAIN
BENZHEXOL HYDROCHLORIDE
N04AA01	PBS/RPBS	 0.168	 0.181	 0.163
	SURVEY	 0.018	 0.020	 0.019
BIPERIDEN HYDROCHLORIDE
N04AA02	PBS/RPBS	 0.046	 0.048	 0.044
	SURVEY	 0.003	 0.002	 0.003
PROCYCLIDINE HYDROCHLORIDE
N04AA04	SURVEY	 0.003	 0.000	 0.000
ETHERS OF TROPINE OR TROPINE DERIVATIVES
BENZTROPINE MESYLATE
N04AC01	PBS/RPBS	 0.632	 0.457	 0.505
	SURVEY	 0.072	 0.053	 0.038
DOPAMINERGIC AGENTS
DOPA AND DOPA DERIVATIVES
LEVODOPA with BENSERAZIDE
N04BA02	PBS/RPBS	 0.466	 0.480	 0.505
	SURVEY	 0.001	 0.003	 0.003
LEVODOPA with CARBIDOPA
N04BA02	PBS/RPBS	 0.864	 0.873	 0.873
	SURVEY	 0.003	 0.007	 0.005
ADAMANTANE DERIVATIVES
AMANTADINE HYDROCHLORIDE
N04BB01	PBS/RPBS	 0.092	 0.095	 0.096
	SURVEY	 0.002	 0.000	 0.000
DOPAMINE AGONISTS
BROMOCRIPTINE MESYLATE
N04BC01	PBS/RPBS	 0.043	 0.038	 0.030
	SURVEY	 0.000	 0.000	 0.000
CABERGOLINE
N04BC06	PBS/RPBS	 0.099	 0.164	 0.217
	SURVEY	 0.000	 0.000	 0.000
PERGOLIDE
N04BC02	PBS/RPBS	 0.038	 0.036	 0.032
	SURVEY	 0.000	 0.000	 0.000
MONOAMINE OXIDASE TYPE B INHIBITORS
SELEGILINE HYDROCHLORIDE
N04BD01	PBS/RPBS	 0.172	 0.150	 0.134
	SURVEY	 0.001	 0.000	 0.002
OTHER DOPAMINERGIC AGENTS
ENTACAPONE
N04BX02	PBS/RPBS	 0.099	 0.102	 0.107
	SURVEY	 0.000	 0.001	 0.001
NERVOUS SYSTEM
PSYCHOLEPTICS
ANTIPSYCHOTICS
PHENOTHIAZINE WITH DIMETHYLAMINOPROPYL GROUP
CHLORPROMAZINE HYDROCHLORIDE
N05AA01	PBS/RPBS	 0.220	 0.213	 0.201
	SURVEY	 0.025	 0.017	 0.017
PHENOTHIAZINE WITH PIPERAZINE STRUCTURE
FLUPHENAZINE DECANOATE
N05AB02	PBS/RPBS	 0.483	 0.410	 0.362
	SURVEY	 0.009	 0.007	 0.000
FLUPHENAZINE HYDROCHLORIDE
N05AB02	SURVEY	 0.001	 0.002	 0.001
PROCHLORPERAZINE
N05AB04	PBS/RPBS	 0.151	 0.145	 0.139
	SURVEY	 0.047	 0.040	 0.036
TRIFLUOPERAZINE HYDROCHLORIDE
N05AB06	PBS/RPBS	 0.161	 0.136	 0.117
	SURVEY	 0.021	 0.017	 0.013
PHENOTHIAZINE WITH PIPERIDINE STRUCTURE
PERICYAZINE
N05AC01	PBS/RPBS	 0.089	 0.086	 0.083
	SURVEY	 0.017	 0.016	 0.011
THIORIDAZINE HYDROCHLORIDE
N05AC02	PBS/RPBS	 0.136	 0.093	 0.069
	SURVEY	 0.046	 0.032	 0.022
BUTYROPHENONE DERIVATIVES
HALOPERIDOL
N05AD01	PBS/RPBS	 0.470	 0.412	 0.370
	SURVEY	 0.035	 0.035	 0.028
THIOXANTHENE DERIVATIVES
FLUPENTHIXOL
N05AF01	PBS/RPBS	 0.150	 0.145	 0.147
	SURVEY	 0.004	 0.002	 0.001
THIOTHIXENE
N05AF04	SURVEY	 0.001	 0.000	 0.000
ZUCLOPENTHIXOL
N05AF05	PBS/RPBS	 0.176	 0.201	 0.220
	SURVEY	 0.004	 0.003	 0.003
DIPHENYLBUTYLPIPERIDINE DERIVATIVES
PIMOZIDE
N05AG02	SURVEY	 0.016	 0.016	 0.013
NERVOUS SYSTEM
PSYCHOLEPTICS
ANTIPSYCHOTICS
DIAZEPINES, OXAZEPINES AND THIAZEPINES
CLOZAPINE
N05AH02	PBS/RPBS	 0.036	 0.039	 0.042
	SURVEY	 0.408	 0.231	 0.098
OLANZAPINE
N05AH03	PBS/RPBS	 2.416	 2.771	 2.881
	SURVEY	 0.122	 0.039	 0.032
QUETIAPINE
N05AH04	PBS/RPBS	 0.238	 0.395	 0.531
	SURVEY	 0.009	 0.009	 0.013
NEUROLEPTICS, IN TARDIVE DYSKINESIA
TETRABENAZINE
N05AK01	PBS/RPBS	 0.014	 0.015	 0.016
	SURVEY	 0.000	 0.000	 0.000
BENZAMIDES
AMISULPRIDE
N05AL05	PBS/RPBS	 0.000	 0.053	 0.320
	SURVEY	 0.000	 0.000	 0.001
LITHIUM
LITHIUM CARBONATE
N05AN01	PBS/RPBS	 0.886	 0.885	 0.872
	SURVEY	 0.303	 0.208	 0.197
OTHER ANTIPSYCHOTICS
RISPERIDONE
N05AX08	PBS/RPBS	 0.702	 0.757	 0.777
	SURVEY	 0.013	 0.017	 0.017
ANXIOLYTICS
BENZODIAZEPINE DERIVATIVES
ALPRAZOLAM
N05BA12	PBS/RPBS	 2.702	 2.914	 3.072
	SURVEY	 0.794	 0.708	 0.815
BROMAZEPAM
N05BA08	PBS/RPBS	 0.015	 0.013	 0.013
	SURVEY	 0.174	 0.168	 0.163
CLOBAZAM
N05BA09	SURVEY	 0.078	 0.075	 0.078
DIAZEPAM
N05BA01	PBS/RPBS	 5.326	 5.278	 5.236
	SURVEY	 1.098	 0.978	 0.927
LORAZEPAM
N05BA06	SURVEY	 0.454	 0.376	 0.364
OXAZEPAM
N05BA04	PBS/RPBS	 2.818	 2.711	 2.621
	SURVEY	 .0.484	 0.426	 0.389
NERVOUS SYSTEM
PSYCHOLEPTICS
ANXIOLYTICS
AZASPIRODECANEDIONE DERIVATIVES
BUSPIRONE HYDROCHLORIDE
N05BE01	PBS/RPBS	 0.004	 0.003	 0.004
	SURVEY	 0.012	 0.008	 0.011
HYPNOTICS AND SEDATIVES
BARBITURATES, PLAIN
AMYLOBARBITONE SODIUM
N05CA02	SURVEY	 0.022	 0.020	 0.006
BENZODIAZEPINE DERIVATIVES
FLUNITRAZEPAM
N05CD03	PBS/RPBS	 0.099	 0.049	 0.072
	SURVEY	 0.643	 0.528	 0.576
MIDAZOLAM
N05CD08	SURVEY	 0.003	 0.003	 0.003
NITRAZEPAM
N05CD02	PBS/RPBS	 2.619	 2.512	 2.383
	SURVEY	 0.403	 0.364	 0.316
TEMAZEPAM
N05CD07	PBS/RPBS	 5.010	 4.538	 4.214
	SURVEY	 1.262	 1.249	 1.139
TRIAZOLAM
N05CD05	SURVEY	 0.019	 0.024	 0.027
BENZODIAZEPINE RELATED DRUGS
ZOLPIDEM
N05CF02	SURVEY	 0.489	 0.964	 1.138
ZOPICLONE
N05CF01	PBS/RPBS	 0.044	 0.064	 0.082
	SURVEY	 0.120	 0.137	 0.136
OTHER HYPNOTICS AND SEDATIVES
CHLORMETHIAZOLE EDISYLATE
N05CM02	SURVEY	 0.002	 0.002	 0.001
NERVOUS SYSTEM
PSYCHOANALEPTICS
ANTIDEPRESSANTS
NON SELECTIVE MONOAMINE REUPTAKE INHIBITORS
AMITRIPTYLINE HYDROCHLORIDE
N06AA09	PBS/RPBS	 2.490	 2.549	 2.606
	SURVEY	 0.594	 0.589	 0.659
CLOMIPRAMINE HYDROCHLORIDE
N06AA04	PBS/RPBS	 0.238	 0.225	 0.217
	SURVEY	 0.062	 0.053	 0.048
DESIPRAMINE HYDROCHLORIDE
N06AA01	PBS/RPBS	 0.005	 0.000	 0.000
	SURVEY	 0.007	 0.000	 0.000
DOTHIEPIN HYDROCHLORIDE
N06AA16	PBS/RPBS	 1.393	 1.303	 1.200
	SURVEY	 0.509	 0.435	 0.381
DOXEPIN HYDROCHLORIDE
N06AA12	PBS/RPBS	 1.217	 1.149	 1.065
	SURVEY	 0.216	 0.187	 0.155
IMIPRAMINE HYDROCHLORIDE
N06AA02	PBS/RPBS	 0.437	 0.405	 0.373
	SURVEY	 0.107	 0.088	 0.081
NORTRIPTYLINE HYDROCHLORIDE
N06AA10	PBS/RPBS	 0.185	 0.195	 0.151
	SURVEY	 0.059	 0.046	 0.038
TRIMIPRAMINE MALEATE
N06AA06	SURVEY	 0.052	 0.039	 0.033
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
CITALOPRAM
N06AB04	PBS/RPBS	 5.904	 7.425	 8.603
	SURVEY	 0.038	 0.054	 0.058
FLUOXETINE HYDROCHLORIDE
N06AB03	PBS/RPBS	 4.225	 4.324	 4.525
	SURVEY	 0.013	 0.035	 0.038
FLUVOXAMINE
N06AB08	PBS/RPBS	 1.354	 1.533	 1.687
	SURVEY	 0.007	 0.008	 0.044
PAROXETINE
N06AB05	PBS/RPBS	 6.789	 6.928	 6.732
	SURVEY	 0.033	 0.040	 0.033
SERTRALINE
N06AB06	PBS/RPBS	14.684	15.300	16.251
	SURVEY	 0.067	 0.096	 0.087
NERVOUS SYSTEM
PSYCHOANALEPTICS
ANTIDEPRESSANTS
MONOAMINE OXIDASE INHIBITORS, NON-SELECTIVE
PHENELZINE SULPHATE
N06AF03	PBS/RPBS	 0.037	 0.018	 0.009
	SURVEY	 0.007	 0.007	 0.000
TRANYLCYPROMINE SULPHATE
N06AF04	PBS/RPBS	 0.249	 0.253	 0.236
	SURVEY	 0.076	 0.054	 0.054
MONOAMINE OXIDASE TYPE A INHIBITORS
MOCLOBEMIDE
N06AG02	PBS/RPBS	 3.206	 2.668	 2.230
	SURVEY	 0.014	 0.008	 0.008
OTHER ANTIDEPRESSANTS
MIANSERIN HYDROCHLORIDE
N06AX03	PBS/RPBS	 0.306	 0.265	 0.239
	SURVEY	 0.007	 0.004	 0.004
MIRTAZAPINE
N06AX11	PBS/RPBS	 0.236	 1.364	 2.616
	SURVEY	 0.001	 0.009	 0.021
NEFAZODONE
N06AX06	PBS/RPBS	 0.443	 0.368	 0.300
	SURVEY	 0.035	 0.024	 0.020
REBOXETINE
N06AX18	PBS/RPBS	 0.000	 0.024	 0.099
	SURVEY	 0.000	 0.000	 0.003
VENLAFAXINE
N06AX16	PBS/RPBS	 6.137	 7.225	 8.531
	SURVEY	 0.035	 0.066	 0.078
PSYCHOSTIMULANTS AND NOOTROPICS
CENTRALLY ACTING SYMPATHOMIMETICS
DEXAMPHETAMINE SULPHATE
N06BA02	PBS/RPBS	 1.482	 1.598	 1.674
	SURVEY	 0.433	 0.375	 0.373
METHYLPHENIDATE
N06BA04	SURVEY	 0.538	 0.472	 0.728
MODAFINIL
N06BA07	SURVEY	 0.000	 0.000	 0.001
NERVOUS SYSTEM
PSYCHOANALEPTICS
ANTI-DEMENTIA DRUGS
ANTICHOLINESTERASES
DONEPEZIL
N06DA02	PBS/RPBS	 0.496	 0.703	 0.798
	SURVEY	 0.010	 0.017	 0.018
GALANTAMINE
N06DA04	PBS/RPBS	 0.004	 0.074	 0.153
	SURVEY	 0.000	 0.002	 0.002
RIVASTIGMINE
N06DA03	PBS/RPBS	 0.067	 0.089	 0.079
	SURVEY	 0.002	 0.004	 0.000
NERVOUS SYSTEM
OTHER NERVOUS SYSTEM DRUGS
PARASYMPATHOMIMETICS
ANTICHOLINESTERASES
PYRIDOSTIGMINE BROMIDE
N07AA02	PBS/RPBS	 0.108	 0.086	 0.096
	SURVEY	 0.000	 0.002	 0.002
CHOLINE ESTERS
BETHANECHOL CHLORIDE
N07AB02	PBS/RPBS	 0.039	 0.035	 0.032
	SURVEY	 0.004	 0.003	 0.002
DRUGS USED IN ADDICTIVE DISORDERS
DRUGS USED IN NICOTINE DEPENDENCE
BUPROPION
N07BA02	PBS/RPBS	 3.018	 0.788	 0.551
	SURVEY	 0.103	 0.017	 0.011
NICOTINE
N07BA01	PBS/RPBS	 0.009	 0.012	 0.008
	SURVEY	 0.014	 0.008	 0.007
DRUGS USED IN ALCOHOL DEPENDENCE
ACAMPROSATE
N07BB03	PBS/RPBS	 0.114	 0.095	 0.091
	SURVEY	 0.000	 0.000	 0.001
NALTREXONE
N07BB04	PBS/RPBS	 0.056	 0.052	 0.053
	SURVEY	 0.009	 0.003	 0.001
DRUGS USED IN OPIOID DEPENDENCE
METHADONE HYDROCHLORIDE
N07BC02	PBS/RPBS	 0.301	 0.308	 0.311
	SURVEY	 1.384	 1.627	 0.803
ANTIVERTIGO PREPARATIONS
ANTIVERTIGO PREPARATIONS
BETAHISTINE
N07CA01	SURVEY	 0.309	 0.326	 0.319
OTHER NERVOUS SYSTEM DRUGS
OTHER NERVOUS SYSTEM DRUGS
RILUZOLE
N07XX02	PBS/RPBS	 0.000	 0.000	 0.006
	SURVEY	 0.000	 0.000	 0.000
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTS
ANTIPROTOZOALS
AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
NITROIMIDAZOLE DERIVATIVES
METRONIDAZOLE
P01AB01	PBS/RPBS	 0.121	 0.123	 0.125
	SURVEY	 0.123	 0.111	 0.105
TINIDAZOLE
P01AB02	PBS/RPBS	 0.010	 0.008	 0.008
	SURVEY	 0.014	 0.012	 0.010
ANTIMALARIALS
QUINOLINE DERIVATIVES
CHLOROQUINE
P01BA01	SURVEY	 0.041	 0.033	 0.020
HYDROXYCHLOROQUINE SULPHATE
P01BA02	PBS/RPBS	 0.368	 0.391	 0.424
	SURVEY	 0.001	 0.002	 0.001
PRIMAQUINE PHOSPHATE
P01BA03	SURVEY	 0.000	 0.000	 0.001
BIGUANIDES
PROGUANIL
P01BB01	SURVEY	 0.033	 0.024	 0.009
METHANOLQUINOLINES
MEFLOQUINE
P01BC02	SURVEY	 0.003	 0.003	 0.002
QUININE BISULPHATE
P01BC01	PBS/RPBS	 0.369	 0.368	 0.329
	SURVEY	 0.036	 0.030	 0.028
QUININE SULPHATE
P01BC01	PBS/RPBS	 0.568	 0.569	 0.562
	SURVEY	 0.053	 0.042	 0.041
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTS
ANTHELMINTICS
ANTINEMATODAL AGENTS
TETRAHYDROPYRIMIDINE DERIVATIVES
PYRANTEL EMBONATE
P02CC01	PBS/RPBS	 0.001	 0.001	 0.001
	SURVEY	 0.000	 0.000	 0.000
RESPIRATORY SYSTEM
NASAL PREPARATIONS
DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
SYMPATHOMIMETICS, PLAIN
OXYMETAZOLINE
R01AA05	PBS/RPBS	 0.011	 0.009	 0.008
	SURVEY	 0.007	 0.009	 0.009
XYLOMETAZOLINE
R01AA07	SURVEY	 0.003	 0.002	 0.003
ANTIALLERGIC AGENTS, EXCL CORTICOSTEROIDS
LEVOCABASTINE
R01AC02	PBS/RPBS	 0.003	 0.003	 0.004
	SURVEY	 0.006	 0.002	 0.002
SODIUM CROMOGLYCATE
R01AC01	PBS/RPBS	 0.001	 0.001	 0.002
	SURVEY	 0.001	 0.001	 0.001
CORTICOSTEROIDS
BECLOMETHASONE DIPROPIONATE
R01AD01	PBS/RPBS	 0.146	 0.205	 0.100
	SURVEY	 0.733	 0.515	 0.314
BUDESONIDE
R01AD05	PBS/RPBS	 0.302	 0.057	 0.068
	SURVEY	 0.036	 1.581	 1.541
MOMETASONE FUROATE
R01AD09	SURVEY	 0.573	 1.017	 1.262
OTHER NASAL PREPARATIONS
IPRATROPIUM BROMIDE
R01AX03	PBS/RPBS	 0.051	 0.060	 0.060
	SURVEY	 0.073	 0.048	 0.034
NASAL DECONGESTANTS FOR SYSTEMIC USE
SYMPATHOMIMETICS
PSEUDOEPHEDRINE
R01BA02	PBS/RPBS	 0.003	 0.003	 0.003
	SURVEY	 0.073	 0.265	 0.274
RESPIRATORY SYSTEM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
ADRENERGICS, INHALANTS
NON-SELECTIVE BETA-ADRENOCEPTOR AGONISTS
ORCIPRENALINE
R03AB03	SURVEY	 0.011	 0.010	 0.007
SELECTIVE BETA-2-ADRENOCEPTOR AGONISTS
EFORMOTEROL
R03AC13	PBS/RPBS	 1.481	 1.374	 1.029
	SURVEY	 0.001	 0.002	 0.002
FENOTEROL HYDROBROMIDE
R03AC04	SURVEY	 0.015	 0.000	 0.000
SALBUTAMOL
R03AC02	PBS/RPBS	22.152	21.325	19.954
	SURVEY	 7.877	 7.891	 7.567
SALMETEROL
R03AC12	PBS/RPBS	 1.979	 1.261	 0.859
	SURVEY	 0.001	 0.002	 0.003
TERBUTALINE SULPHATE
R03AC03	PBS/RPBS	 3.303	 2.865	 2.483
	SURVEY	 1.828	 1.433	 1.132
ADRENERGICS AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
SALBUTAMOL with IPRATROPIUM BROMIDE
R03AK04	PBS/RPBS	 0.055	 0.057	 0.039
	SURVEY	 0.011	 0.012	 0.012
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,INHALANTS
GLUCOCORTICOIDS
BECLOMETHASONE DIPROPIONATE
R03BA01	PBS/RPBS	 4.254	 1.685	 0.743
	SURVEY	 0.365	 0.121	 0.026
BUDESONIDE
R03BA02	PBS/RPBS	10.009	 8.319	 6.094
	SURVEY	 0.095	 0.078	 0.053
FLUTICASONE
R03BA05	PBS/RPBS	 6.289	 5.745	 4.766
	SURVEY	 0.084	 0.105	 0.114
ANTICHOLINERGICS
IPRATROPIUM BROMIDE
R03BB01	PBS/RPBS	15.069	14.516	11.028
	SURVEY	 0.067	 0.046	 0.050
TIOTROPIUM BROMIDE
R03BB04	PBS/RPBS	 0.000	 0.000	 2.029
	SURVEY	 0.000	 0.000	 0.003
RESPIRATORY SYSTEM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,INHALANTS
ANTIALLERGIC AGENTS, EXCL CORTICOSTEROIDS
NEDOCROMIL
R03BC03	PBS/RPBS	 0.567	 0.441	 0.359
	SURVEY	 0.002	 0.002	 0.003
SODIUM CROMOGLYCATE
R03BC01	PBS/RPBS	 0.484	 0.353	 0.263
	SURVEY	 0.001	 0.001	 0.001
ADRENERGICS FOR SYSTEMIC USE
ALPHA- AND BETA-ADRENOCEPTOR AGONISTS
EPHEDRINE
R03CA02	SURVEY	 0.007	 0.005	 0.007
SELECTIVE BETA-2-ADRENOCEPTOR AGONISTS
SALBUTAMOL
R03CC02	PBS/RPBS	 0.031	 0.038	 0.054
	SURVEY	 0.010	 0.009	 0.016
TERBUTALINE SULPHATE
R03CC03	PBS/RPBS	 0.097	 0.000	 0.000
	SURVEY	 0.000	 0.000	 0.000
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
XANTHINES
CHOLINE THEOPHYLLINATE
R03DA02	SURVEY	 0.046	 0.029	 0.023
THEOPHYLLINE
R03DA04	PBS/RPBS	 1.160	 0.929	 0.812
	SURVEY	 0.231	 0.223	 0.145
LEUKOTRIENERECEPTOR ANTAGONISTS
MONTELUKAST
R03DC03	PBS/RPBS	 0.000	 0.000	 0.087
	SURVEY	 0.185	 0.163	 0.137
ZAFIRLUKAST
R03DC01	SURVEY	 0.004	 0.003	 0.006
RESPIRATORY SYSTEM
COUGH AND COLD PREPARATIONS
EXPECTORANTS,EXCL COMBINATIONS WITH ANTITUSSIVES
MUCOLYTICS
ACETYLCYSTEINE
R05CB01	PBS/RPBS	 0.005	 0.005	 0.005
	SURVEY	 0.000	 0.000	 0.000
BROMHEXINE HYDROCHLORIDE
R05CB02	SURVEY	 0.026	 0.027	 0.029
COUGH SUPPRESSANTS, EXCL.COMBINATIONS WITH EXPECTORANTS
OPIUM ALKALOIDS AND DERIVATIVES
CODEINE
R05DA04	PBS/RPBS	 0.181	 0.169	 0.157
	SURVEY	 0.050	 0.039	 0.036
PHOLCODINE
R05DA08	PBS/RPBS	 0.004	 0.003	 0.003
	SURVEY	 0.006	 0.005	 0.005
PHOLCODINE with PSEUDOEPHEDRINE
R05DA20	SURVEY	 0.001	 0.000	 0.000
RESPIRATORY SYSTEM
ANTIHISTAMINES FOR SYSTEMIC USE
ANTIHISTAMINES FOR SYSTEMIC USE
AMINOALKYL ETHERS
DIPHENHYDRAMINE
R06AA02	SURVEY	 0.002	 0.003	 0.002
SUBSTITUTED ALKYLAMINES
BROMPHENIRAMINE COMBINATIONS
R06AB51	SURVEY	 0.015	 0.011	 0.011
DEXCHLORPHENIRAMINE
R06AB02	SURVEY	 0.380	 0.372	 0.355
PHENIRAMINE
R06AB05	SURVEY	 0.068	 0.071	 0.074
SUBSTITUTED ETHYLENE DIAMINES
MEPYRAMINE
R06AC01	SURVEY	 0.001	 0.001	 0.001
PHENOTHIAZINE DERIVATIVES
METHDILAZINE HYDROCHLORIDE
R06AD04	SURVEY	 0.054	 0.038	 0.035
PROMETHAZINE
R06AD02	PBS/RPBS	 0.176	 0.165	 0.157
	SURVEY	 0.741	 0.771	 0.764
TRIMEPRAZINE
R06AD01	SURVEY	 0.017	 0.012	 0.012
PIPERAZINE DERIVATIVES
CETIRIZINE
R06AE07	PBS/RPBS	 0.035	 0.045	 0.049
	SURVEY	 0.029	 0.021	 0.025
OTHER ANTIHISTAMINES FOR SYSTEMIC USE
AZATADINE MALEATE
R06AX09	SURVEY	 0.018	 0.012	 0.010
CYPROHEPTADINE HYDROCHLORIDE
R06AX02	PBS/RPBS	 0.482	 0.457	 0.428
	SURVEY	 0.081	 0.067	 0.063
FEXOFENADINE
R06AX26	PBS/RPBS	 0.733	 0.747	 0.735
	SURVEY	 0.181	 0.233	 0.181
LORATADINE
R06AX13	PBS/RPBS	 0.204	 0.202	 0.190
	SURVEY	 0.069	 0.047	 0.033
LORATADINE with PSEUDOEPHEDRINE
R06AX13	SURVEY	 0.003	 0.001	 0.001
SENSORY ORGANS
OPHTHALMOLOGICALS
ANTIGLAUCOMA PREPARATIONS AND MIOTICS
SYMPATHOMIMETICS IN GLAUCOMA THERAPY
APRACLONIDINE
S01EA03	PBS/RPBS	 0.023	 0.022	 0.026
	SURVEY	 0.000	 0.000	 0.000
BRIMONIDINE
S01EA05	PBS/RPBS	 0.793	 0.828	 0.774
	SURVEY	 0.092	 0.072	 0.057
DIPIVEFRINE
S01EA02	PBS/RPBS	 0.317	 0.221	 0.154
	SURVEY	 0.020	 0.009	 0.007
PARASYMPATHOMIMETICS
CARBACHOL
S01EB02	PBS/RPBS	 0.022	 0.020	 0.016
	SURVEY	 0.001	 0.001	 0.000
ECOTHIOPATE IODIDE
S01EB03	PBS/RPBS	 0.015	 0.000	 0.000
PILOCARPINE
S01EB01	PBS/RPBS	 0.673	 0.545	 0.432
	SURVEY	 0.058	 0.031	 0.024
CARBONIC ANHYDRASE INHIBITORS
ACETAZOLAMIDE
S01EC01	PBS/RPBS	 0.129	 0.121	 0.112
	SURVEY	 0.028	 0.027	 0.025
BRINZOLAMIDE
S01EC04	PBS/RPBS	 0.122	 0.237	 0.258
	SURVEY	 0.013	 0.021	 0.025
DORZOLAMIDE
S01EC03	PBS/RPBS	 0.140	 0.148	 0.141
	SURVEY	 0.028	 0.010	 0.011
BETA BLOCKING AGENTS
BETAXOLOL HYDROCHLORIDE
S01ED02	PBS/RPBS	 1.090	 0.978	 0.820
	SURVEY	 0.130	 0.088	 0.074
LEVOBUNOLOL
S01ED03	PBS/RPBS	 0.208	 0.174	 0.142
	SURVEY	 0.038	 0.020	 0.012
TIMOLOL MALEATE
S01ED01	PBS/RPBS	 2.547	 2.375	 2.136
	SURVEY	 0.354	 0.300	 0.258
SENSORY ORGANS
OPHTHALMOLOGICALS
ANTIGLAUCOMA PREPARATIONS AND MIOTICS
PROSTAGLANDIN ANALOGUES
BIMATOPROST
S01EE03	PBS/RPBS	 0.000	 0.000	 0.553
	SURVEY	 0.000	 0.000	 0.002
LATANOPROST
S01EE01	PBS/RPBS	 4.213	 4.935	 4.942
	SURVEY	 0.002	 0.008	 0.010
VARIOUS
ALL OTHER THERAPEUTIC PRODUCTS
ALL OTHER THERAPEUTIC PRODUCTS
DETOXIFYING AGENTS FOR CYTOSTATIC TREATMENT
CALCIUM FOLINATE
V03AF03	PBS/RPBS	 0.001	 0.001	 0.001
	SURVEY	 0.000	 0.000	 0.000